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Abstract: RECQ5 is a member of the RecQ DNA helicase family, a group of highly conserved proteins
that are essential for the maintenance of genomic stability. It has been shown that RECQ5 interacts with
RAD51 recombinase and disrupts RAD51-ssDNA filaments to suppress aberrant homologous recombina-
tion events. The aim of this thesis was to explore the functional significance of the physical interaction of
RECQ5 with the MUS81-EME1 endonuclease, which is known to process late replication intermediates
at common fragile sites (CFSs) during early mitosis to facilitate chromosome segregation. We have found
that RECQ5 associates with CFS loci in a manner dependent on MUS81 and is required for the appear-
ance of MUS81- dependent chromatid breaks/gaps at CFSs following replication stress, a phenomenon
termed ”expression of CFSs”, which is required for proper sister chromatid disjunction. Accordingly,
RECQ5-depleted cells showed increased frequency of anaphase bridges and micronuclei, and accumula-
tion of CFS-associated 53BP1 nuclear bodies in G1 cells, phenotypes related to defective chromosome
segregation. Moreover, we found that mutational inactivation of the helicase or RAD51-binding domains
of RECQ5 increased binding of RAD51 to CFSs, impaired their expression and led to aberrant sister
chromatid separation. Consistent with these findings, RECQ5 was found to counteract the inhibitory
effect of RAD51 on 3’- flap cleavage by MUS81-EME1 in vitro. Lastly, we have found that expression
of CFSs is dependent on phosphorylation of RECQ5 by CDK1 at Ser727. These results suggest that
RECQ5 disrupts RAD51 filaments formed on stalled replication forks at CFS and hence facilitates their
processing by the MUS81-EME1 endonuclease for proper sister chromatid disjunction during mitosis.
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RECQ5	   is	  a	  member	  of	   the	  RecQ	  DNA	  helicase	   family,	  a	  group	  of	  highly	  conserved	  
proteins	   that	   are	   essential	   for	   the	   maintenance	   of	   genomic	   stability.	   It	   has	   been	  
shown	   that	   RECQ5	   interacts	   with	   RAD51	   recombinase	   and	   disrupts	   RAD51-­‐ssDNA	  
filaments	   to	   suppress	  aberrant	  homologous	   recombination	  events.	  The	  aim	  of	   this	  
thesis	  was	  to	  explore	  the	  functional	  significance	  of	  the	  physical	  interaction	  of	  RECQ5	  
with	   the	   MUS81-­‐EME1	   endonuclease,	   which	   is	   known	   to	   process	   late	   replication	  
intermediates	   at	   common	   fragile	   sites	   (CFSs)	   during	   early	   mitosis	   to	   facilitate	  
chromosome	  segregation.	  We	  have	  found	  that	  RECQ5	  associates	  with	  CFS	   loci	   in	  a	  
manner	   dependent	   on	   MUS81	   and	   is	   required	   for	   the	   appearance	   of	   MUS81-­‐
dependent	   chromatid	   breaks/gaps	   at	   CFSs	   following	   replication	   stress,	   a	  
phenomenon	   termed	   "expression	   of	   CFSs",	   which	   is	   required	   for	   proper	   sister	  
chromatid	   disjunction. Accordingly, RECQ5-­‐depleted	   cells	   showed	   increased	  
frequency	  of	  anaphase	  bridges	  and	  micronuclei,	  and	  accumulation	  of	  CFS-­‐associated	  
53BP1	   nuclear	   bodies	   in	   G1	   cells,	   phenotypes	   related	   to	   defective	   chromosome	  
segregation.	   Moreover,	   we	   found	   that	   mutational	   inactivation	   of	   the	   helicase	   or	  
RAD51-­‐binding	   domains	   of	   RECQ5	   increased	   binding	   of	   RAD51	   to	   CFSs,	   impaired	  
their	   expression	   and	   led	   to	   aberrant	   sister	   chromatid	   separation.	   Consistent	   with	  
these	  findings,	  RECQ5	  was	  found	  to	  counteract	  the	  inhibitory	  effect	  of	  RAD51	  on	  3’-­‐
flap	  cleavage	  by	  MUS81-­‐EME1	  in	  vitro.	  Lastly,	  we	  have	  found	  that	  expression	  of	  CFSs	  
is	  dependent	  on	  phosphorylation	  of	  RECQ5	  by	  CDK1	  at	  Ser727.	  These	  results	  suggest	  
that	  RECQ5	  disrupts	  RAD51	  filaments	  formed	  on	  stalled	  replication	  forks	  at	  CFS	  and	  
hence	   facilitates	   their	   processing	   by	   the	   MUS81-­‐EME1	   endonuclease	   for	   proper	  






RECQ5	  ist	  ein	  Mitglied	  der	  Familie	  der	  RecQ	  DNA	  Helikasen,	  einer	  Gruppe	  von	  stark	  
konservierten	   Proteinen,	   welche	   essentiell	   sind	   für	   die	   Aufrechterhaltung	  
genomischer	  Stabilität.	  Es	  wurde	  gezeigt,	  dass	  RECQ5	  mit	  der	  RAD51	  Rekombinase	  
interagiert	   und	   RAD51-­‐ssDNA-­‐Filamente	   zerstört,	   um	   anomale	   homologe	  
Rekombinationsereignisse	   zu	   unterdrücken.	   Das	   Ziel	   dieser	   Arbeit	   war	   es,	   die	  
funktionelle	  Bedeutung	  der	  physikalischen	   Interaktion	  von	  RECQ5	  mit	  der	  MUS81-­‐
EME1	  Endonuklease	  zu	  untersuchen.	  Letztere	  ist	  bekannt	  dafür,	  während	  der	  frühen	  
Mitose	   späte	   Replikationszwischenprodukte	   bei	   Common	   Fragile	   Sites	   (CFSs)	   zu	  
prozessieren,	   um	   die	   Verteilung	   der	   Chromosomen	   zu	   erleichtern.	   Wir	   haben	  
festgestellt,	  dass	  RECQ5	   in	  Abhängigkeit	  von	  MUS81	  mit	  CFS	  Loci	  assoziiert	   ist	  und	  
für	  das	  Erscheinungsbild	  von	  MUS81-­‐abhängigen	  Chromatidbrüchen/-­‐lücken	  bei	  CFS	  
infolge	   Replikationsstress	   verantwortlich	   ist.	   Dieses	   Phänomen	   wird	   „CFS	  
Expression“	   genannt	   und	   ist	   erforderlich,	   um	   die	   einwandfreie	   Trennung	   von	  
Schwesterchromatiden	   zu	   gewährleisten.	   Dementsprechend	   zeigen	   RECQ5-­‐
depletierte	  Zellen	  eine	  erhöhte	  Anzahl	  an	  Anaphasen-­‐Brücken	  und	  Micronuclei	  und	  
eine	   Anhäufung	   von	   CFS-­‐assoziierten	   53BP1	   nuclear	   bodies	   in	   G1	   Zellen	   auf	   -­‐	  
allesamt	   Phänotypen,	   welche	   mit	   fehlerhafter	   Chromosomenverteilung	  
zusammenhängen.	   Ausserdem	   haben	   wir	   festgestellt,	   dass	   die	   mutationelle	  
Inaktivierung	   der	   Helikase-­‐	   oder	   RAD51-­‐Bindungsdomäne	   von	   RECQ5	   zur	  
verstärkten	   Bindung	   von	   RAD51	   zu	   CFS	   führt,	   die	   CFS	   Expression	   behindert	   und	  
fehlerhafte	   Chromosomenverteilung	   hervorruft.	   In	   Übereinstimmung	   mit	   diesen	  
Ergebnissen	   hat	   sich	   herausgestellt,	   dass	   RECQ5	   dem	   inhibitorischen	   Effekt	   von	  
RAD51	   auf	   die	   MUS81-­‐EME1-­‐abhängige	   Abspaltung	   von	   3’-­‐Flaps	   in	   vitro	  




abhängig	   ist	   von	   der	   Phosphorylierung	   von	   RECQ5	   auf	   Ser727	   durch	   CDK1.	   Diese	  
Resultate	   lassen	   vermuten,	   dass	   RECQ5	   RAD51-­‐Filamente	   zerstört,	   welche	   an	  
angehaltenen	   Replikationsgabeln	   bei	   CFS	   entstehen,	   und	   dadurch	   deren	  
Prozessierung	  durch	  die	  MUS81-­‐EME1	  Endonuklease	  erleichtert,	  um	  eine	  fehlerfreie	  








3.1	  -­	  Genomic	  instability	  and	  cancer	  
	  
Genomic	   instability	   is	   a	   distinctive	  marker	  of	  many	   cancers.	   In	   hereditary	   cancers,	  
genomic	   instability	   arises	   from	   mutations	   in	   DNA	   repair	   genes	   that	   drive	  
tumorigenesis	   (mutator	   phenotype	   hypothesis)	   [1].	   In	   sporadic	   (non-­‐hereditary)	  
cancers,	   the	  molecular	   basis	   of	   tumorigenesis	   remains	   elusive,	   but	   new	  evidences	  
are	   in	   disagreement	   with	   the	   mutator	   phenotype	   hypothesis.	   Instead,	   recent	  
observations	   support	   the	   oncogene-­‐induced	   DNA	   replication	   stress	   model,	   where	  
mutations	   in	  tumor	  suppressor	  genes,	  such	  as	  TP53,	  ATM	  and	  CDKN2A	  arising	  as	  a	  
consequence	   of	   oncogene-­‐induced	   DNA	   damage	   drive	   genomic	   instability	   and	  
tumorigenesis	   [2].	   The	   increasing	   importance	   of	   the	   involvement	   of	   genomic	  
instability	   in	   cancer	   development,	   prompted	   D.	   Hanahan	   and	   R.	   A.	   Weinberg	   to	  
include	  genome	   instability	   as	   an	  enabling	   characteristic	   in	   the	  hallmarks	  of	   cancer	  
[3].	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  





The	  hallmarks	  of	  cancer,	   first	  proposed	   in	  2000	  [4],	   include	  six	  biological	  principles	  
that	  reflect	  the	  capabilities	   for	  tumor	  growth	  and	  metastatic	  dissemination	  (Figure	  
1).	   Apart	   from	   sustaining	   proliferative	   signaling,	   evading	   growth	   suppressor,	  
resisting	   cell	   death,	   enabling	   replicative	   immortality,	   inducing	   angiogenesis,	   and	  
activating	   invasion	   and	   metastasis,	   the	   authors	   included	   two	   other	   emerging	  
hallmarks:	  reprogramming	  of	  energy	  metabolism	  and	  evading	  immune	  destruction,	  
and	   two	   enabling	   characteristics:	   genome	   instability	   and	   mutation,	   and	   tumor-­‐
promoting	  inflammation	  [3]	  (Figure	  2).	  	  	  	  	  	  	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  










3.2	  –	  DNA	  repair	  pathways	  
	  
The	   human	   genome	   is	   constantly	   threatened	   by	   endogenous	   reactive	  metabolites	  
and	   environmental	   mutagens	   (i.e.	   UV	   light,	   ionizing	   radiations,	   chemicals)	   [5].	  
Spontaneous	  DNA	  damage	  can	  also	  affect	   the	  stability	  of	   the	  genome,	  and	  several	  
base	   mutations	   have	   been	   described,	   including	   base	   substitutions,	   deletions	   and	  
insertions	  of	  one	  or	  more	  base	  pairs	  [6].	  The	  sequencing	  of	  the	  human	  genome	  [7]	  
brought	   to	   light	   many	   proteins	   involved	   in	   different	   DNA-­‐repair	   pathways.	  
Mutations	   in	   DNA-­‐repair	   genes	   drive	   the	   oncogenesis	   process	   and	   are	   associated	  
with	   hereditary	   diseases	   [8].	   Accumulation	   of	   DNA	   damage	   above	   a	   certain	  
threshold	   alters	   physiological	   metabolic	   processes	   (e.g.	   DNA	   synthesis,	   mRNA	  
production,	   etc.),	   arrests	   cell	   proliferation	   and	   triggers	   apoptosis	   [5].	   In	   order	   to	  
protect	  the	  integrity	  of	  the	  genome,	  the	  cell	  has	  developed	  a	  repertoire	  of	  efficient	  
repair	   mechanisms.	   The	   base-­‐excision	   repair	   (BER)	   removes	   non-­‐helix-­‐distorting	  
base	   lesions,	   such	   as	   those	   derived	   from	   oxidation,	   deamination	   and	   alkylation	  
processes.	  The	  nucleotide-­‐excision	  repair	   (NER),	   in	  contrast	  to	  BER,	  can	  repair	  DNA	  
adducts	   generated	   by	   UV	   light	   (e.g.	   pyrimidine	   dimers,	   6,4-­‐photoproducts)	   or	  
chemicals	   (benzo[a]pyren).	   Mismatch	   repair	   (MMR)	   eliminates	   mis-­‐incorporated	  
nucleotides,	   deletion/insertion	   loops	   generated	   by	   polymerase	   slippage	   during	  
replication	   and	   mismatches	   generated	   by	   spontaneous	   deamination	   of	   5-­‐
methylcytosine	   or	   by	   strand	   exchange	   during	   DNA	   recombination.	   Homologous	  
recombination	  (HR)	  and	  non-­‐homologous	  end-­‐joining	  (NHEJ)	  constitute	  mechanisms	  




	  	  	  	  	  	  	  	  	   	  
Figure	   3.	   Endogenous	   and	   exogenous	   agents	   can	   threaten	   the	   genome.	   The	   lesions	   generated	   by	   toxic	  
agents	  are	  repaired	  by	  different	  and	  specialized	  DNA	  repair	  mechanisms.	  SSB:	  Single-­‐stranded	  break;	  DSB:	  
Double-­‐stranded	  break.	  [9]	  
HR,	  considered	  to	  be	  error-­‐free,	  takes	  advantage	  of	  the	  intact	  homologous	  region	  on	  
undamaged	  sister	  chromatid	   to	  copy	   the	   information	   lost	  by	  DNA	  breakage.	  NHEJ,	  
does	  not	  require	  a	  template	  to	  restore	  the	  continuity	  of	  damaged	  DNA	  strands,	  but	  
it	  can	  lead	  to	  loss	  of	  genetic	  information.	  DNA	  damage	  triggers	  an	  ordered	  action	  of	  
numerous	  proteins,	  a	  process	  often	  called	   the	  DNA	  damage	   response	   (DDR).	  After	  
DNA	  damage	   occurs,	   sensor	   proteins	   recognize	   the	   damage	   and	   activate	   the	  DDR	  
pathway.	   Transducer	   proteins	   amplify	   the	   damage-­‐induced	   signal	   and,	   in	   turn,	  
activate	  effector	  proteins.	   The	   latter	  promote	   cell	   cycle	  arrest,	   allowing	   the	   repair	  
enzymes	   to	   correct	   the	   damage	   [10].	   It	   is	   clear	   that	   the	   study	   of	   the	   molecular	  
mechanisms	  of	   these	  processes	   is	  essential	   to	  understand	  the	  biogenesis	  of	   tumor	  






3.3	  –	  DNA	  replication	  
	  
The	   first	   evidence	   that	   complementary	   base	   pairing	   provides	   the	   basis	   for	   DNA	  
replication	  comes	   from	  Watson	  and	  Crick	   studies	   revealing	   that	   the	  nucleotides	   in	  
the	  template	  strand	  guide	  the	  complementary	  bases	   in	  the	  new	  strand	  [11].	  Given	  
the	   antiparallel	   nature	   of	   the	  DNA	  molecule,	  DNA	  polymerases	  move	   in	   a	   3’	   -­‐>	   5’	  
direction	  on	  the	  template	  strand,	  and	  therefore	  they	  add	  nucleotides	  only	  in	  the	  5’	  -­‐
>	   3’	   direction.	   The	   leading	   strand	   is	   synthesized	   continuously,	   while	   the	   lagging	  
strand	   has	   to	   be	   synthesized	   in	   short,	   discontinuous	   segments,	   known	   as	  Okazaki	  
fragments.	   The	   result	   of	   this	   mechanism	   is	   that	   the	   new	   strand	   grows	   in	   the	  
opposite	   direction	   of	   the	   movement	   of	   the	   replication	   fork	   (Figure	   4).	   DNA	  
polymerases	  are	  accurate	  enzymes,	  with	  an	  error	  rate	  of	   less	  than	  one	  mistake	  for	  
every	   107	   nucleotides	   added.	  Moreover,	   some	  DNA	   polymerases	   have	   an	   intrinsic	  
proofreading	   activity.	   In	   addition,	   the	   post-­‐replicative	   mismatch	   repair	   system	   is	  
able	   to	   distinguish	   mismatches	   in	   the	   newly	   synthesized	   DNA	   strand	   [12].	   The	  
replication	   process	   can	   be	   subdivided	   into	   three	   different	   steps:	   initiation,	  
elongation	   and	   termination.	   The	   major	   enzymatic	   functions	   carried	   out	   at	   the	  






Figure	  4.	  Schematic	  of	  the	  replication	  fork.	  DNA	  replication	  on	  the	  leading	  strand	  proceeds	  continuously	  (5’	  
-­‐>	  3’),	  meanwhile	  on	  the	  lagging	  strand	  DNA	  synthesis	  occurs	  in	  a	  discontinuous	  manner	  (3’	  -­‐>	  5’).	  In	  green,	  
RNA	  primers	   initiate	  synthesis	  on	   the	   leading	  strand,	  and	  every	  Okazaki	   fragments	  on	   the	   lagging	  strand.	  
[13]	  	  
	  
	   The	   replication	  machinery	   is	   a	  massive	   complex	   coordinating	  many	  proteins	  
that	  all	  work	  at	  the	  site	  of	  replication,	  forming	  the	  replisome	  responsible	  for	  copying	  
the	   genome	   in	   the	   cell.	   DNA	   replication	   is	   an	   energetically	   costly	   process.	   In	   G1	  
phase	   of	   the	   cell	   cycle,	   many	   DNA	   replication	   regulatory	   processes	   are	   initiated.	  
Polymerase	   ε,	   synthesizes	   DNA	   in	   a	   continuous	   fashion	   in	   the	   direction	   of	   DNA	  
unwinding.	  Polymerase	  δ	   replicates	  DNA	  on	   the	   template,	   lagging	  strand	  [14].	  The	  
Okazaki	  fragments	  produced	  by	  Pol	  δ	  are	  between	  100	  and	  200	  bases	  in	  lengths.	  The	  
lagging	  strand	  contains	  longer	  stretches	  of	  ssDNA,	  coated	  by	  single-­‐stranded	  binding	  
proteins,	   which	   stabilizes	   the	   ssDNA	   regions	   by	   preventing	   secondary	   structure	  
formation	   or	   other	   recombinogenic	   events.	   In	   eukaryotes,	   ssDNA	   stabilization	   is	  
carried	  out	  by	   the	  heterotrimeric	  complex	  named	  replication	  protein	  A	   (RPA)	  [15].	  
Each	  Okazaki	  fragment	  is	  preceded	  by	  an	  RNA	  primer,	  which	  is	  displaced	  by	  the	  next	  




displaced,	   leading	  to	  the	  creation	  of	   flap	  structures	  that,	  eventually,	  are	  processed	  
by	  endonucleases,	  such	  as	  FEN1.	  The	  gap	  formed	  is	  then	  sealed	  by	  DNA	  ligase	  I	  [16,	  
17].	   Besides	   polymerases,	   helicase	   enzymes	   have	   an	   essential	   role	   during	   the	  
replication	   process.	   The	   replicative	   helicase	   unwinds	   the	   parental	   DNA	   duplex,	  
exposing	   the	   two	   ssDNA	   templates,	   which	   become	   the	   substrates	   of	   DNA	  
polymerases.	   In	   eukaryotes,	   three	   different	   polymerases	   are	   required	   for	   DNA	  
replication:	   α,	   δ,	   ε	   [18,	   19].	   Since	   polymerases	   cannot	   start	   the	   nucleotide	  
polymerization	   on	   their	   own,	   but	   they	   require	   a	   primer	   to	   initiate	   the	   process,	  
polymerase	  α	  creates	  a	  short	  nucleotide	  RNA	  molecule	  followed	  by	  10-­‐20	  DNA	  bases	  
at	  the	  origins	  [20,	  21].	  Although,	  Pol	  α	  is	  required	  for	  replication,	  it	  cannot	  continue	  
the	  process.	  Instead,	  following	  the	  RNA	  primer	  synthesis,	  clamp	  loaders	  perform	  the	  
switching	  required	  to	  exchange	  Pol	  α	  with	  Pol	  ε	  to	  the	  leading	  strand,	  and	  Pol	  δ	  to	  
each	  of	  the	  Okazaki	  fragments	  on	  the	  lagging	  strand.	  	  
	  
	  
Figure	   5.	   Replication	   on	   the	   leading	   and	   lagging	   strand	   is	   performed	   by	   Pol	   ε	   and	   Pol	   δ,	   respectively.	  
Replisome	   factors	   (FPC,	   Claspin,	   And1,	   RFC)	   regulate	   polymerase	   function	   and	   coordinate	  DNA	   synthesis	  
with	  unwinding	  of	  the	  template	  strand	  by	  Cdc25-­‐MCM-­‐GINS.	  The	  replisome	  is	  also	  linked	  with	  checkpoint	  





	   The	   replicative	   helicase	   is	   a	   hexameric	   complex	   comprised	   of	   the	   mini-­‐
chromosome	  maintenance	  proteins,	  MCM2-­‐7	  [22].	  The	  MCM	  helicase	  is	  an	  ATPase,	  
and	   it	   is	   required	   during	   the	   whole	   S	   phase	   for	   DNA	   replication	   [23,	   24].	   MCM	  
proteins	  are	   recruited	   to	   replication	  origins	   in	  G1	  phase	  and	   redistributed	  on	  DNA	  
during	   S	   phase	   to	   the	   replication	   forks	   [25].	   Although	   prokaryotic	   replication	  
initiates	  at	  a	   single	   locus,	   in	  eukaryotes,	  DNA	   replication	   fires	   from	  multiple	  origin	  
sites.	   Origins	   are	   recognized	   by	   the	  origin	   recognition	   complex	   (ORC)	   [26].	   During	  
late	  mitosis	   and	  G1	  phase,	   Cdt1	   and	  Cdc6	  proteins	   associate	  with	  origin	   sites	  and	  
recruit	  MCM2-­‐6	  helicases	  [25,	  27].	  When	  double	  hexamers	  of	  the	  MCM2-­‐7	  complex	  
are	   loaded,	   the	  pre-­‐replication	   complex	   (pre-­‐RC)	   is	   formed	   [28],	   replication	  origins	  
are	  considered	  to	  be	  licensed	  to	  initiate	  DNA	  synthesis.	  Origin	  firing	  is	  orchestrated	  
by	  kinases,	  the	  cyclin	  E-­‐CDK2	  at	  the	  onset	  of	  S	  phase	  and	  Cdc7	  kinase	  before	  origin	  
firing	  [29].	  At	  this	  point,	  origin	  melting	  occurs	  and	  DNA	  unwinding	  exposes	  the	  two	  
strands	  of	  the	  duplex	  as	  template	  for	  DNA	  polymerases	  (Figure	  5).	  	  
	  	  	  	  	  
3.3.1	  –	  S-­‐phase	  DNA	  damage	  checkpoint	  
	  
The	   genetic	   information	   must	   be	   preserved	   during	   every	   cell	   division,	   thus	   DNA	  
replication	  needs	   to	   be	   completed	  with	  high	   fidelity	   [13].	   For	   this	   reason,	   the	   cell	  
cycle	   includes	  checkpoints	   in	  order	  to	  ensure	  that	  a	  certain	  process	   is	  started	  only	  
after	  the	  previous	  one	  has	  been	  successfully	  completed	  [30].	  Moreover,	  since	  many	  
checkpoint	   factors	   are	   involved	   in	   the	   DNA	   damage	   response	   [31],	   checkpoints	  
contribute	  to	  the	  avoidance	  of	  genomic	  instability	  [32].	  
	   Excessive	   or	   premature	   initiation	   of	   replication	   can	   cause	   replication	   stress	  




particularly	   sensitive	   to	   replication	   stress.	   In	   response	   to	   excessive	   DNA	   damage,	  
normal	  cells	  block	  the	  cell	  cycle	  in	  G1	  phase,	  before	  DNA	  replication	  starts,	  or	  in	  G2	  
phase,	   before	   entering	   into	   mitosis.	   Typically,	   replication	   fork-­‐associated	   damage	  
provokes	   a	   response	   that	   slows	   down	   the	   replication	   progress	   throughout	   the	   S	  
phase,	   by	   controlling	   forks	   and	   initiation	   events.	   In	   mammals,	   DNA	   damage	  
response	   is	   mediated	   by	   three	   kinases,	   the	   Ataxia	   Telangiectasia	   Mutated	   (ATM)	  
kinase,	   the	  ATM-­‐	   and	  RAD3-­‐related	   (ATR)	   kinase,	   and	   the	  DNA-­‐dependent	  protein	  
kinase	   (DNA-­‐PK)	   [34].	   All	   of	   these	   three	   protein	   kinases	   belong	   to	   the	  
phosphoinositide	   3-­‐kinase	   (PI3K)-­‐related	   kinases	   (PIKKs)	   that	   share	   sequence	  
homology	   and	   phosphorylate	   an	   overlapping	   set	   of	   substrates.	   Based	   on	   their	  
function	   and	   sequence	   homology,	   the	   PIKK	   family	   can	   be	   grouped	   into	   six	  
subfamilies	   [34].	   Their	   targets	   often	   have	   a	   SQ/TQ	   cluster	   domains	   (SCDs).	   ATR	   is	  
hyperactivated	   in	   response	   to	   a	   variety	   of	   DNA	   damages	   and	   is	   essential	   for	   cell	  
viability.	  On	  the	  contrary,	  ATM	   is	  activated	   following	  DSB	   formation	  and	   its	   loss	   in	  
budding	  yeast	  is	  not	  lethal.	  However,	  in	  mammals,	  mutations	  of	  ATM	  or	  ATR	  lead	  to	  
enhanced	  cancer	   susceptibility.	  Once	  ATM	  or	  ATR	  are	   localized	   to	   the	   site	  of	  DNA	  
damage	   and	   activated	   by	   DNA	   sensing	   proteins,	   both	   kinases	   initiate	   a	   signaling	  
cascade	   that	   transduces	   the	   signal	   through	   the	  mediator	   proteins	   Claspin,	   BRCA1,	  
MDC1	   and	   53BP1	   to	   the	   effector	   kinases	   CHK1	   and	   CHK2.	   Effector	   kinases	   are	  
transiently	   recruited	   to	   DNA	   damage	   sites	   and	   are	   released	   after	   their	   activation,	  
allowing	  transmission	  of	  the	  checkpoint	  response	  to	  a	  range	  of	  effector	  proteins.	  
	   The	  G1/S	  and	  G2/M	  checkpoints	  represent	  a	  global	  cellular	  response,	  in	  which	  
checkpoint	  kinases	  regulate	  cell-­‐cycle	  events	  distant	   from	  the	   lesions	  that	   initiated	  
the	  signaling	   [35].	  On	   the	  contrary,	   the	   intra-­‐S	  phase	  checkpoint	  does	  not	  prevent	  
cell-­‐cycle	   transition	   but	   it	   slows	   down	   DNA	   replication	   in	   the	   presence	   of	   DNA	  
damage	  during	  S-­‐phase	  by	  inhibiting	  origin	  firing	  or	  reducing	  the	  rate	  of	  replication	  




to	  DNA	   lesions	   that	   can	   be	   far	   from	   the	   origins	   being	   regulated	   [36].	   Checkpoint-­‐
dependent	  replication	  fork	  slowing	  may,	   if	  the	  checkpoint	  does	  not	  affect	  all	  forks,	  
be	   regulated	   in	   cis	   to	  DNA	  damage	   and	  only	   the	   forks	   encountering	  DNA	  damage	  
would	  be	   slowed.	   The	  drugs	  used	   in	   checkpoint	   response	   studies	   are	  described	   in	  
the	  next	  chapter.	  	  
	   Stalled	   replication	   forks	   can	   be	   stabilized	   during	   the	   S-­‐phase	   checkpoint,	  
allowing	   the	   completion	   of	   replication	   in	   the	   presence	   of	   DNA	   damage	   [37].	  
Moreover,	   the	  S-­‐phase	   checkpoint	  prevents	  excessive	  nuclease	  activity	  and	   ssDNA	  
formation	   at	   stalled	   forks	   [38].	   Lastly,	   checkpoint-­‐mediated	   stabilization	   of	   stalled	  
replication	   forks	   prevents	   fork	   breakage,	   a	   source	   of	   gross	   chromosomal	  
rearrangements	  and	  cell	  death	  [39].	  	  	  	  
	   Sometimes,	   it	   is	   advantageous	   for	   the	   cell	   to	   circumvent	   replicative	   arrests	  
and	   postpone	   the	   repair	   of	   the	   lesions.	   This	   process,	   known	   as	   DNA	   damage	  
tolerance	   (DDT)	   or	   lesion	   bypass,	   can	   be	   accomplished	   in	   two	   different	   pathways	  
that	   are	   well	   evolutionary	   conserved	   from	   yeast	   to	   human.	   In	   translesion	   DNA	  
synthesis	   (TLS),	   the	   replicative	   polymerase	   is	   replaced	   with	   a	   specialized	   TLS	  
polymerase	   that	   binds	   to	   the	   PCNA,	   and	   replicates	   past	   the	   damage,	   but	   this	  
mechanism	   has	   high	   risk	   of	   mutagenesis	   [40].	   In	   template	   switching,	   considered	  
accurate,	  the	  stalled	  polymerase	  makes	  use	  of	  an	  alternative,	  undamaged	  template,	  
that	  is	  the	  newly	  synthesized	  daughter	  strand	  on	  the	  sister	  chromatid	  [41].	  
	  
3.4	  –	  Replication	  stress	  and	  cancer	  
	  
Amongst	   the	   hallmarks	   of	   cancer,	   one	   can	   find	   the	   oncogene-­‐induced	   replication	  
stress	  and	  DNA	  damage.	  Interestingly,	  enhanced	  replication	  stress	  has	  been	  shown	  
to	   confer	   a	   weakness	   to	   cancer	   cells	   (Table	   1)	   [42,	   43].	   Targeting	   excessive	  




approach	   for	   specific	   killing	   of	   these	   cells	   [43-­‐45].	   Oncogene-­‐induced	   replication	  
stress	   is	   characterized	   by	   a	   rapid	   activation	   of	   ATR	   and	   Chk1	   in	   response	   to	  
abnormal	  DNA	  replication	   intermediates,	  excessive	  origin	   firing	  and	  DNA	  breakage	  
at	   fragile	  sites,	  regions	  that	  replicate	   late	  with	  difficulties	   (described	   later).	  Studies	  
have	   underlined	   a	   gene-­‐dosage	   mechanism	   of	   ATR	   and	   Chk1,	   since	   mice	  
heterozygous	   for	   these	   kinases	   are	   tumor	  prone,	  while	   low	   level	   of	  ATR	   contrasts	  
tumor	   formation,	   due	   to	   a	   sufficiently	   strong	   replication	   stress	   in	   cells	   expressing	  
oncogenes,	  leading	  to	  senescence	  or	  cell	  death	  [46].	  	  
	  
	  





	   Taken	   together,	   these	   observations	   elucidate	   a	   still	   unknown	   multistep	  
process	  of	  tumor	  development	   involving	  the	  DNA	  damage	  response	  (DDR)	  and	  the	  
replication	   stress	   response	   (RSR).	   ATR/Chk1	   (replication	   stress	   response)	   and	  
ATM/Chk2	   (DSB	   response)	   checkpoint	   kinases	   can	   prevent	   oncogene-­‐driven	  
tumorigenesis	   [44,	   45].	   ATR/Chk1	   haploinsufficiency,	   which	   limits	   RSR	   and	   DDR	  
signaling	  can,	  under	  these	  conditions,	  promote	  cancer.	  However,	  in	  advanced	  stage	  
tumors	  with	   enhanced	   replication	   stress	   that	   already	   trespassed	   the	   DDR	   barrier,	  
ATR/Chk1-­‐mediated	   RSR	   can	   facilitate	   the	   tumor	   to	   deal	   with	   the	   persistent	  
replication	  stress	  (Figure	  6).	  
	  
	  	  	  	  
Figure	   6.	   The	   ATR/Chk1	   pathway	   during	   tumorigenesis.	   Oncogene-­‐activated	   early	   lesions	   experience	  
replication	  stress	  and	  DNA	  damage,	  which	   in	   turn	  triggers	   the	  repair	   response	  and	  checkpoint	  activation,	  
towards	   senescence	  or	  death	  of	   tumor	  cells.	  Tumor	  cells	   that	  defeat	   the	  DDR	  barrier,	   can	  continue	   their	  
proliferation.	   Tumors	   in	   an	   advanced	   stage,	  where	   oncogene	   expression	   promote	   a	   constant	   replication	  





	  	  	  
3.4.1	  –	  Drugs	  used	  to	  study	  checkpoint	  responses	  
	  
Although	   natural	   impediments,	   such	   as	   secondary	   DNA	   structures	   (e.g.	   G-­‐
quadruplexes),	   RNA-­‐DNA	  hybrids	   or	   tightly	   bound	   transcription	   complexes	   (e.g.	   at	  
rDNA	   or	   tRNA	   genes)	   can	   create	   an	   obstacle	   for	   the	   replication	   fork	   [48],	   DNA-­‐
damaging	   and	   fork	   stalling	   agents	   are	   extensively	   used	   to	   provoke	   a	   checkpoint	  
response	  that,	  usually,	  does	  not	  occur	  during	  natural	  or	  endogenous	  replication	  fork	  
impediment	   formation	   (Table	   2).	   The	   checkpoint	   response	   is	   more	   prone	   to	   be	  
activated	  in	  cells	  deficient	  for	  DNA	  repair.	  Other	  lesions	  that	  expose	  primed	  ssDNA	  
and	   activate	   the	   replication	   checkpoint	   arise	   when	   replicative	   helicase	   and	  
polymerase	  functions	  are	  uncoupled	  [49].	  To	  trigger	  the	  replication	  checkpoint,	  one	  





Table	  2.	  The	  table	  summarizes	  S.	  cerevisiae	  checkpoint	  responses,	  depending	  on	  the	  treatment.	  [50]	  
	  
HU	  inhibits	  ribonucleotide	  reductase	  (RNR)	  by	  reducing	  the	  reactive	  tyrosyl	  radical	  in	  
the	   active	   center	   of	   the	   enzyme	   [51].	   If	   RNR	   is	   inhibited,	   when	   replication	   is	  
initiated,	  dNTP	  pools	  are	  depleted,	  and	  this	   leads	  to	  a	  stalling	  of	  DNA	  polymerases	  
[52].	   Aphidicolin	   directly	   inhibits	   DNA	   polymerases	   [53]	   without	   affecting	   the	  
replicative	   helicase	   [24].	   Thus,	   polymerases	   are	   blocked,	   but	   MCM	   helicases	  




checkpoint	   [54].	   It	   is	   worth	   to	   mention	   that	   low	   doses	   of	   aphidicolin	   enhance	  
replication	   stress	  by	   slowing	  down	   the	  progression	  of	   replication	   forks,	  while	  high	  
dose	  of	  this	  drug	  provokes	  a	  complete	  arrest	  of	  polymerase	  movement.	  	  
	   On	  the	  other	  hand,	  interstrand	  crosslinks	  (ICLs;	  e.g.	  caused	  by	  cisplatin)	  block	  
the	  MCM	  helicase	  in	  front	  of	  the	  replication	  fork.	  In	  this	  case,	  there	  is	  no	  immediate	  
activation	   of	   the	   replication	   checkpoint,	   and	   no	   uncoupling	   of	   helicase	   and	  
polymerase.	  Usually,	   the	   replication	   fork	   pauses	   20-­‐40	  base	  pairs	   from	   the	   lesion,	  
and	   structure-­‐specific	   nucleases	   will	   process	   the	   template	   or	   nascent	   strands	  
generating	  ssDNA,	  and	  this	  will	  lead	  to	  checkpoint	  activation	  [55,	  56].	  
	   Alkylation	   of	   DNA	   can	   be	   formed	   by	   methyl	   methanesulfonate	   (MMS)	  
treatment.	  Alkylation	  creates	  bulky	  lesions	  that	  do	  not	  activate	  checkpoint	  response	  
per	  se,	  but	  require	  a	  collision	  with	  a	  replication	  fork	  to	  trigger	  checkpoint	  activation	  
[37].	  
	   Ionizing	   radiation	   (IR)	   or	   radiomimetic	   drugs	   (e.g.	   bleomycin)	   cause	   DSBs	  
which,	   in	   turn,	   activate	   the	   DNA	   damage	   response	   through	   the	   ATM	   kinase,	   and	  
after	  processing,	  through	  ATR	  [57].	  On	  the	  other	  hand,	  UV	  treatment	  induces	  ATR-­‐
mediated	   response,	   because	   of	   pyrimidine	   dimer	   formation	   and	   this	   adduct	   is	  
recognized	  by	   the	  NER	  machinery,	  which	   creates	   a	   ssDNA	  patch	  during	   the	   repair	  
process	  [58].	  	  
	   Replication	   forks	   can	   also	   be	   arrested	   after	   camptothecin	   (CPT)	   treatment,	  
which	   inhibits	  DNA	   topoisomerase	   I	   (Top1)	  by	  blocking	  DNA	   relegation	   after	   Top1	  
created	   a	   ssDNA	   nick	   and	   becomes	   covalently	   linked	   to	   the	   DNA	   end	   [59].	   The	  
replication	  run-­‐off	  model	  [60]	  shows	  that	  replication	  forks	  running	  into	  these	  ssDNA	  
nicks	  are	  converted	  into	  DSBs.	  The	  torsional	  stress	  generated	  by	  Top1	  inhibition	  may	  
lead	   to	   fork	   slowing,	   and	   this	   mechanism	   is	   actively	   mediated	   by	   Mus81	  





3.5	  –	  RecQ	  helicase	  family	  
	  
Helicases	   are	  motor	   proteins	   that	   utilize	   chemical	   energy	   derived	   from	  nucleotide	  
triphosphate	   (NTP)	   hydrolysis	   for	   unwinding	   nucleic	   acid	   duplexes	   [62].	   The	   RecQ	  
helicase	   family	   is	   conserved	   in	  many	   species:	  S.	   cerevisiae,	  S.	   pombe,	  Arabidopsis,	  
Drosophila,	  C.	   elegans	   and	  mammals	   [63,	   64].	   In	  humans	  and	  mice,	   there	  are	   five	  
RecQ	   helicase	   family	  members:	   RECQ1,	  WRN,	   RECQ4,	   RECQ5	   and	   BLM	   (Figure	   7).	  
These	  motor	  proteins	  are	  required	  for	  genomic	  stability	  and	  therefore	  are	  classified	  
as	  genome	  caretakers	  (Table	  4).	  
	   Helicase	  proteins	  are	  subdivided	  into	  six	  superfamilies	  (SF1	  to	  SF6),	  and	  RecQ	  
helicases	  belong	   to	   the	  SF2	  helicase	  superfamily.	  They	  have	   in	  common	  a	  helicase	  
domain	  (350-­‐400	  a.a.),	  containing	  seven	  conserved	  motifs	  that	  include	  the	  Walker	  A	  
and	  B	  boxes	  involved	  in	  ATP	  binding	  and	  hydrolysis,	  respectively.	   In	  addition,	  RecQ	  
helicases	   contain	   the	   RQC	   (RecQ	   C-­‐terminal)	   domain	   that	   features	   a	   zinc-­‐binding	  
motif,	   a	   helix-­‐hairpin-­‐helix,	   winged-­‐helix	   (WH)	   domain,	   and	   a	   β-­‐hairpin	  motif	   [65,	  
66].	   This	   domain	   mediates	   binding	   of	   these	   helicases	   to	   G-­‐quadruplex	   DNA	   and	  
stabilizes	  helicase	  binding	  to	  other	  structures.	  The	  RQC	  domain	  of	  RECQ1	  organizes	  
the	  binding	  to	  ssDNA-­‐dsDNA	  junctions,	  and	  the	  β-­‐hairpin	  couples	  ATP	  hydrolysis	  to	  
DNA	  unwinding	   [67,	  68].	  Moreover,	  WRN’s	  RQC	  domain	   can	  enter	   in	   contact	  with	  
the	  phosphate	  backbone	  on	  5’-­‐ssDNA	  overhangs	  [66].	  	   	  





Figure	  7.	  Domain	  structure	  of	  the	  RecQ	  helicase	  family	  in	  human	  and	  the	  homologs	  found	  in	  S.	  cerevisiae	  
and	  E.	  coli.	  [69]	  
	  
WRN	   and	   BLM	  helicases	   also	   contain	   the	  HRDC	   (Helicase	   and	   RNaseD	   C-­‐terminal)	  
domain	  [65],	  which	  mediates	  their	  recruitment	  to	  laser-­‐induced	  DSBs	  [70]	  and	  sites	  
of	   MMS-­‐	   and	   mitomycin	   C-­‐induced	   DNA	   damage	   [71].	   RecQ	   helicases	   possess	   a	  
DNA-­‐dependent	   ATPase	   and	   an	   ATP-­‐dependent	   3’-­‐>5’	   DNA	   helicase	   activity,	   and	  
also	  a	  DNA	  strand	  annealing	  activity.	  RecQ	  enzymes	  are	  involved	  in	  processes	  such	  
as	  DNA	  replication,	  disruption	  of	  recombination	  intermediates,	  joint	  molecules	  and	  






Table	  4.	  Effect	  of	  human	  RecQ	  helicase	  family	  depletion	  on	  cell	  proliferation,	  tumor	  growth	  and	  sensitivity	  
to	  chemotherapy/radiation.	  Adapted	  from	  [73].	  
	  
	   	  RECQ1	  helicase	  is	  the	  shortest	  of	  the	  human	  RecQ	  family	  members,	  and	  it	  is	  
involved	   in	   branch	   migration	   and	   restart	   of	   reversed	   forks	   during	   S	   phase	   upon	  
topoisomerase	  I	  inhibition	  [74].	  Mutation	  in	  RECQ1	  gene	  is	  not	  linked	  to	  any	  human	  
disease	  [75].	  	  
	   WRN	  is	  the	  only	  RecQ	  helicase	  that	  contains	  a	  3’-­‐>5’	  exonuclease	  activity,	  and	  
it	  binds	  onto	  overhanging	  5’	  ends	  of	  the	  guide	  strand	  of	  duplex	  DNA	  and	  cleaves	  the	  
target	   strand,	   degrading	   substrates	   found	  during	  DNA	   repair	   and	   intermediates	   in	  
DNA	   replication	   [76].	   Inherited	   loss-­‐of-­‐function	   mutations	   in	   human	   WRN	   gene	  




cellular	   lifespan	   (median	   age	   of	   death	   47	   years).	   WS	   patients	   suffer	   from	  
osteoporosis,	  athero-­‐	  and	  arteriosclerosis	  and	  a	  high	  cancer	  incidence	  [77].	  	  
	   Mutations	   in	   RECQ4	   gene	   lead	   to	   autosomal	   recessive	   disorders,	   known	   as	  
Rothmund-­‐Thomson	   syndrome,	   RAPADILINO	   syndrome	   and	   Baller-­‐Gerold	  
syndrome.	  Cells	  carrying	  defects	   in	  RECQ4	  genes	  show	  chromosomal	  abnormalities	  
and	   genomic	   instability.	   RECQ4	   interacts	  with	   the	   replication	  machinery,	   and	   it	   is	  
involved	  in	  replication	  progression	  and	  stress	  response	  [78].	  
	   The	   BLM	   and	   RECQ5	   helicases	  will	   be	   described	   in	  more	   details	   in	   the	   next	  
chapters.	  
	  
3.5.1	  -­‐	  BLM	  helicase	  
	  
Genetic	   defects	   in	   the	   BLM	   gene	   are	   responsible	   for	   the	   autosomal,	   recessive	  
disease	   called	   Bloom	   syndrome	   (BS).	   This	   disorder	   is	   characterized	   by	   retarded	  
growth,	   head	   development	   defects	   and	   cancer	   predisposition.	   The	   skin	   of	   BS	  
patients	  presents	  erythema	  that	  become	  chronic	  to	  sun	  exposition	  [79].	  	  	  
	   BS	   cells	   show	   elevated	   frequency	   of	   sister	   chromatid	   exchanges	   (SCEs)	   [80]	  
due	   to	   aberrant	   processing	   of	   recombination	   intermediates	   [81].	   BLM	   acts	   in	  
complex	  with	  replication	  protein	  A	  and	  TOPOIIIα,	  and	  it	  suppresses	  the	  formation	  of	  
crossover	   products	   generated	   by	   resolution	   of	   homologous	   recombination	  
intermediates	   containing	  Holliday	   junctions	   [82].	   As	   already	  mentioned	   in	   chapter	  
3.5.1,	   the	   BTR-­‐containing	   BLM	   complex	   can	   catalyze	   double	   Holliday	   junction	  
dissolution,	  a	  reaction	  that	  produces	  only	  non-­‐crossover	  products.	  
	   BLM	  has	  been	  linked	  to	  interstrand	  crosslink	  (ICL)	  DNA	  repair	  pathway.	  The	  FA	  
pathway	   is	   implicated	   in	   cellular	   resistance	   to	   DNA	   ICLs	   and	   other	   forms	   of	  
replication	   stress	   [83].	   The	   FA	   pathway	   leads	   DSBs	   towards	   HR,	   thus	   preventing	  




with	   FA	   core	   complex	   proteins	   to	   recognize	   DNA	   lesions	   [85].	   BLM	   interacts	  with	  
FANCJ	   to	   maintain	   chromosomal	   stability	   [86].	   Therefore,	   BLM	   has	   a	   role	   in	   the	  
recognition	  of	  the	  ICL	  and	  strand	  resection	  of	  a	  DSB,	  together	  with	  FANCJ	  and	  MRN	  




Figure	  8.	  Involvement	  of	  BLM	  helicase	  in	  the	  interstrand	  crosslink	  DNA	  repair	  mechanism.	  Following	  lesion	  
detection,	   nucleases	   incises	   on	   each	   side	   of	   the	   crosslink	   and	   remove	   the	   aberration,	   leaving	   a	   gap	   that	  





an	   important	   role	   in	   mitosis	   to	   resolve	   DNA	   bridging	   between	   sister	   chromatids	  
during	   anaphase,	   promoting	   correct	   chromosome	   segregation	   and	   preventing	  
aneuploidy	  [88,	  89].	  	  
	  
	  
3.5.2	  –	  RECQ5	  helicase	  
	  
Mutations	   in	  RECQ5	  gene	  have	  not	   been	   linked	   to	   any	  human	  disease,	   but	  Recq5	  
knockout	  mice	  show	  elevated	  levels	  of	  sister	  chromatid	  exchange	  and	  predisposition	  
to	  various	  types	  of	  cancer	  (Table	  5)	  [90],	  suggesting	  that	  RECQ5	  plays	  an	  important	  
role	  in	  genome	  stability	  maintenance.	  	  
	  





Although	  RECQ5	  deficiency	   in	  DT40	  cells	  does	  not	  compromise	  genome	  stability,	   it	  
has	   been	   observed	   that	   absence	   of	   both	   RECQ5	   and	   BLM	   in	   these	   cells	   result	   in	  
higher	  levels	  of	  SCEs,	  compared	  to	  the	  level	  of	  SCEs	  in	  BLM-­‐/-­‐	  mutant	  [91].	  Moreover,	  
in	  C.	  elegans,	  absence	  of	  RECQ5	  reduced	  its	  lifespan	  and	  increased	  the	  sensitivity	  to	  
ionizing	  radiation	  [92].	  	  
	   RECQ5	  helicase	  is	  present	  in	  human	  cells	  in	  three	  different	  isoforms,	  RECQ5α,	  
RECQ5β	  and	  RECQ5γ,	  produced	  by	  alternative	  splicing.	  The	  first	  410	  amino	  acids	  of	  
these	  isoforms	  are	  identical	  and	  form	  the	  helicase	  domain	  of	  the	  enzyme.	  RECQ5α	  is	  
the	  shortest	  isoform,	  and	  it	  only	  contains	  the	  helicase	  domain.	  RECQ5β	  contains	  the	  
helicase	  domain,	  a	  RQC	  domain,	  and	  a	  unique	  C-­‐terminal	  domain	  that	  is	  not	  present	  
in	   the	   other	   isoforms	   (Figure	   9).	   RECQ5γ	   is	   comprised	   of	   the	   helicase	   domain	  
followed	  by	  a	  short	  region	  of	  25	  amino	  acids	  [93].	  RECQ5β	  (from	  now	  on	  mentioned	  




Figure	  9.	   Schematic	   representation	  of	  RECQ5	  domain	   for	   its	  enzymatic	  activity	  and	   for	   some	  of	   the	  main	  
interacting	  partners.	  IRI	  domain:	  Internal	  RNAPII-­‐interacting.	  R51B:	  RAD51	  binding	  domain.	  SRI:	  Set2-­‐Rpb1-­‐
interacting.	  PIM:	  PCNA-­‐interacting	  motif.	  
	  
annealing	   activity	   residing	   in	   the	   C-­‐terminal	   domain.	   The	   DNA	   strand-­‐annealing	  
activity	  is	  inhibited	  by	  the	  replication	  protein	  A	  (RPA)	  and	  ATP	  [94].	  	  
	  	   RECQ5	   interacts	   with	   RAD51	   recombinase	   that	   mediates	   DNA	   homology	  
search	   and	   strand	   exchange	   during	   HR	   [90].	   In	   this	   context,	   RECQ5	   can	   disrupt	  
RAD51	   presynaptic	   filaments,	   in	   a	   reaction	   that	   depends	   on	   ATP.	   The	   removal	   of	  
RAD51	   is	   followed	   by	   RPA	   binding	   in	   order	   to	   prevent	   reloading	   of	   RAD51	   and	  






Figure	  10.	  Model	  for	  RECQ5-­‐mediated	  disruption	  of	  RAD51	  presynaptic	  filament	  during	  HR	  proposed	  in	  
[90].	  
	  
	   Interestingly,	  RECQ5	  directly	  interacts	  with	  RNA	  polymerase	  II	  (RNAPII),	  and	  is	  
the	  sole	  member	  of	  the	  RecQ	  helicase	  family	  to	  have	  this	  property	  [95].	  RECQ5	  binds	  
to	  the	  Ser2,5-­‐phosphorylated	  C-­‐terminal	  repeat	  domain	  (CTD)	  of	  the	  largest	  subunit	  
of	  RNAPII	  (Rpb1)	  through	  the	  Set2-­‐Rpb1-­‐interacting	  (SRI)	  domain	  located	  at	  RECQ5	  
C-­‐terminus.	   Moreover,	   RECQ5	   is	   enriched	   on	   transcribed	   genes	   during	   the	  
elongation	  phase	  of	  transcription	  [96].	  In	  the	  context	  of	  active	  transcription,	  RECQ5	  
was	  shown	  to	  act	  as	  an	  elongation	   factor	   to	  maintain	  genomic	  stability	  during	   the	  
transcription	   process.	   RECQ5	   depletion	   promotes	   a	   general	   transcription	   stress,	  






3.6	  –	  Structure-­‐specific	  endonucleases	  
	  
As	   already	   mentioned	   in	   the	   previous	   chapters,	   faithful	   DNA	   duplication	   of	   the	  
genome	   is	   fundamental	   process	   and	   yet	   very	   challenging.	   The	   replication	   fork	   can	  
encounter	   numerous	   obstacles	   during	   DNA	   replication,	   which	   impede	   its	   natural	  
progression.	   Collisions	   between	   the	   replication	  machinery	   and	   lesions	   in	   the	   DNA	  
template	  can	  occur,	  due	  to	  hydrolytic-­‐oxidative	  processes,	  cellular	  metabolites	  and	  
DNA	  damaging	  agents	  [5].	  Replication	  forks	  have	  also	  to	  deal	  with	  obstacles	  arising	  
from	  tightly	  bound	  proteins	  to	  DNA,	  secondary	  structures,	  transcription	  machineries	  
and	   torsional	   stress	   [98].	   Last	   but	   not	   least,	   low	   supplies	   of	   dNTPs	   during	  
compromised	  replication	  dynamics	  can	  retard	  replication	  forks	  progression	  [99].	  	  
Stalled	   replication	   forks	   are	   recognized	   by	   the	   S	   phase	   checkpoint,	   inhibiting	   cell	  
cycle	   progression	   and	   late	   origin	   firing	   [101].	   The	   stalled	   replication	   forks	   are	  
protected	   by	   the	   checkpoint	   itself,	   permitting	   to	   resume	   DNA	   synthesis	   once	   the	  
obstacle	   on	   DNA	   is	   removed.	   Replication	   fork	   restart	   is	   facilitated	   by	   HR,	   which	  
creates	  branched	   intermediates	  between	   sister	   chromatids.	   These	   structures	  must	  
be	   resolved	   by	   generating	   intact	   chromosomes	   before	   cells	   enter	   into	   mitosis.	  
Delays	   in	   replication	   fork	   restart	   can	   lead	   to	   DSB	   formation	   (Figure	   11)	   [102].	   In	  
Escherichia	   coli,	   the	   RuvC	   structure-­‐specific	   nuclease	   processes	   HR	   intermediates	  
and	   replication	   fork	   cleavage,	   in	   order	   to	   allow	   another	   fork	   to	   assemble	   and	  
complete	   DNA	   duplication.	   In	   eukaryotes,	   three	   conserved	   nucleases	   have	   been	  
identified,	   sharing	   similar	   properties	  with	   RuvC,	   but	   not	   biochemically	   equivalent:	  
MUS81-­‐Mms4/MUS81-­‐EME1	   (budding	   yeast/human),	   Yen1/GEN1	   and	   Slx1-­‐






	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	  11.	  Replication	  fork	  recovery.	  1)	  Replication	  fork	  movement	  can	  be	  perturbed	  by	  different	  obstacles,	  
and	   2)	   potentially	   arresting	   the	   replication	   fork	   (inactive	   fork	   in	   grey);	   3)	   replication	   fork	   regresses,	   by	  
annealing	  of	  the	  nascent	  leading	  and	  lagging	  strands	  with	  one	  another,	  leading	  to	  the	  formation	  of	  a	  HJ-­‐like	  
structure.	  Template	  switching	  allows	  leading	  strand	  extension	  (triple	  arrowhead)	  if	  the	  lagging	  strand	  had	  
been	   extended	   further	   than	   the	   leading	   strand	   prior	   to	   regression;	   4)	   if	   the	   obstacle	   is	   removed	   (or	   if	  
template	   switch	  bypass),	  HJ	  branch	  migration	  may	   reset	  an	  active	   fork	   (in	  blue).	  Alternatively,	  deliberate	  
fork	  cleavage	  can	  occur	  5),	  and	  MUS81-­‐EME1	  may	  act	  directly	  on	  the	  replication	  forks	  (red	  arrowhead);	  6)	  
replication	   fork	   cleavage	   may	   occur	   after	   conversion	   of	   the	   three-­‐way	   junction	   into	   a	   four-­‐way	   HJ	  
intermediate.	   7-­‐10)	   Recombination-­‐dependent	   replication/break-­‐	   induced	   replication	   (BIR)	   pathways	   can	  
reactivate	  a	  processive	  replication	  fork	  from	  a	  DSB	  after	  breakage	  or	  spontaneous	  replication	  fork	  collapse.	  
[100]	  
	  	  	  	  
	  
	  









Table	  6.	  Summary	  of	  the	  species-­‐specific	  structure-­‐selective	  endonucleases,	  organized	  by	  their	  binding	  
partners,	  endonuclease	  superfamily,	  and	  the	  pathway	  in	  which	  they	  are	  involved.	  [103]	  
	  
3.6.1	  –	  Mus81-­‐Mms4/MUS81-­‐EME1	  
	  	  
Mus81	  was	   identified	   in	   a	   two-­‐hybrid	   screens	   using	   Rad54	   as	   bait	   in	   S.	   cerevisiae	  
[104]	  and	  the	  DNA	  damage	  response	  kinase	  Cds1	  (ScRad53,	  hCHK2)	  as	  bait	  in	  fission	  
yeast	   [18].	   Mus81	   forms	   a	   heterodimer	   with	   a	   non-­‐nucleolytic	   subunit:	   Mms4	   in	  




Mms4/EME1	   are	   required	   for	   the	   recombination-­‐mediated	   DNA	   repair	   during	  
replication	   fork	   restart,	  and	   for	  yeast	  meiotic	   recombination.	  Mus81	   is	  essential	   in	  
the	   absence	   of	   the	   dHJ	   dissolution	   complex,	   Sgs1-­‐Top3-­‐Rmi1	   [18,	   105]	   in	   S.	  
cerevisiae,	   S.	   pombe,	   A.	   thaliana,	   and	   D.	   melanogaster.	   Loss	   of	   MUS81/EME1	  
increases	  the	  number	  of	  gross	  rearrangements	  [106],	  and	  in	  somatic	  cells,	  MUS81	  is	  
required	  for	  HR	  at	  stalled	  or	  broken	  replication	  forks	  [107,	  108].	  Eukaryotic	  cells	  with	  
defects	  in	  these	  genes	  show	  hypersensitivity	  to	  a	  variety	  of	  replication	  fork	  stalling	  
agents,	  including	  MMS,	  HU	  and	  CPT	  [104,	  109,	  110].	  
	  
	  
Figure	   12.	   Domain	   structure	   and	   architecture	   of	   eukaryotic	   structure-­‐selective	   junction	   endonucleases.	  
Protein	  names	  and	  amino	  acids	  length	  are	  noted	  below	  each	  protein.	  N/D,	  not	  discovered.	  [103]	  
	  
	  
	   The	   substrates	   of	  Mus81-­‐Mms4/MUS81-­‐EME1	   consist	   of	   duplex	  DNA	  with	   a	  
3’-­‐single-­‐stranded	  flap	  (3’-­‐flap),	  double-­‐stranded	  three-­‐way	  junctions	  that	  resemble	  
replication	  forks,	  HJ	  precursors,	  and	  ligated	  HJs	  [111,	  112]	  (Figure	  12).	  Although	  the	  
activity	  of	  the	  Mus81	  complex	  on	  fully-­‐fledged	  HJs	  is	  weak,	  nicked	  HJs	  are	  efficiently	  
resolved	  [113,	  114].	  MUS81	  and	  EME1	  belong	  to	  the	  XPF	  endonuclease	  family	  and	  
contain	  an	  ERCC4	  nuclease	  domain	  and	  a	  tandem	  helix-­‐hairpin-­‐helix	  (HhH)2	  domain	  




the	  equivalent	  domain	  in	  EME1	  evolutionary	  diverged	  and	  is	   inactive.	  Despite	  that,	  
EME1	   is	   essential	   for	   the	   stability	   and	   activity	   of	   MUS81,	   acting	   as	   a	   regulatory	  
subunit.	  MUS81	  can	  also	   interact	  with	  EME2	  [116],	  but	  the	  precise	  role	  of	  MUS81-­‐
EME2	  complex	  in	  mammals	  is	  still	  under	  investigation	  [117].	  	  
	  
3.6.2	  –	  Yen1/GEN1	  	  
	  
GEN1	   (Yen1	   in	   yeast)	  was	   first	   identified	   in	   rice	  as	  OsSEND-­‐1	   [118]	   in	  a	   search	   for	  
novel	   Rad2	   family	   endonucleases.	  GEN1	   (XPG-­‐like	   endonuclease)	   contains	  both	  N-­‐
terminal	   and	   internal	   conserved	   Rad2/XPG	   family	   endonuclease	   domains.	   Rad2	  
(human	  XPG)	  creates	  the	  3’	  incision	  to	  free	  the	  damaged	  nucleotide	  during	  	  NER.	  	  
GEN1	   is	   monomeric	   but	   dimerizes	   on	   HJ	   DNA	   in	   order	   to	   introduce	   symmetric	  
incisions,	   resolving	   HJs	   in	   a	   RuvC-­‐like	   manner.	   Other	   GEN1	   substrates	   include	   5’-­‐
flaps	  and	  replication	  forks	  [119]	  (Figure	  13).	  
	   Deletion	  of	  Yen1	   in	  S.	   cerevisiae	   enhances	   the	   sensitivity	   to	   replication	   fork-­‐
RAD52-­‐dependent	   damage	   in	   mus81Δ	   cells,	   indicating	   that	   Mus81	   and	   Yen1	   can	  
work	   in	   overlapping	   pathways	   during	   processing	   of	   replication	   intermediates	   in	  





	  	  	  	  	   	  
Figure	  13.	  Substrate	  specificity	  of	  eukaryotic	  structure-­‐selective	  junction	  endonucleases.	  Incision	  sites	  




3.6.3	  –	  Slx1-­‐Slx4	  	  
	  
Slx1	  and	  Slx4	  were	  identified	  in	  S.	  cerevisiae	  by	  a	  genetic	  screen	  for	  synthetic	  lethal	  
mutations	  with	  a	  defect	   in	  the	  Sgs1	  helicase	  [105].	  Sequence	  alignment	  revels	  Slx1	  
to	   have	   a	   conserved	   UvrC-­‐intron	   (URI)-­‐endonuclease	   domain	   and	   a	   C-­‐terminal	  
RING/PHD-­‐type	  zinc	  finger	  domain	  (Figure	  12),	  placing	  Slx1	  into	  the	  URI-­‐YIG	  family	  of	  




and	   slx4	   deletion	   phenotypes	   identifies	   these	   genes	   to	   function	   in	   the	  
recombination-­‐mediated	  repair	  of	  stalled	  replication	  forks	  [122].	  	  
	   Slx1-­‐Slx4	   complex	   cleaves	   a	   variety	   of	   DNA	   junctions	   in	   vitro	   showing	  
preference	   for	   Y-­‐shaped	   structure,	   5’-­‐flaps,	   and	   replication	   forks.	   Slx1-­‐Slx4	   has	   an	  
activity	   towards	  mobile	  HJs	  and	  very	   low	  activity	  with	   fixed	  HJs	   [122].	   In	  addition,	  
Slx4	   serves	   as	   a	   scaffolding	   platform	   that	   binds	   to	  Mus81-­‐Eme1,	   XPF-­‐ERCC1,	   and	  
SLX1	  [123],	  forming	  a	  high	  molecular	  weight	  complex.	  Moreover,	  the	  endonuclease	  
activity	   of	   both	  Mus81-­‐Eme1	   and	   Slx1	   is	   stimulated	  by	   Slx4	   [123],	   suggesting	   that	  
the	  increase	  in	  cleavage	  activity	  reflects	  a	  formation	  of	  a	  proper	  heteromeric	  protein	  
structure.	  
	  
3.7	  –	  Homologous	  recombination	  and	  Holliday	  Junction	  intermediates	  
	  
Homologous	   recombination	   (HR)	   is	   a	   fundamental	   process	   in	   both	   mitotic	   and	  
meiotic	   cells.	   In	   meiosis,	   HR	   is	   responsible	   for	   genetic	   diversity	   during	   the	  
production	  of	  haploid	  gametes.	   In	  somatic	  cells,	  HR	  pathway	  leads	  to	  an	  error-­‐free	  
repair	  of	  DSBs,	  and	  thus	  it	  maintains	  genomic	  stability.	  	  
	   HR,	   in	   mitotic	   cells,	   requires	   an	   intact	   sister	   chromatid	   that	   it	   uses	   for	   the	  
homologous	  pairing	  and	  strand	  exchange	  with	  the	  damaged	  chromatid.	  These	  early	  
interactions	   are	   destabilized	   to	   promote	   non-­‐crossover	   (NCO)	   structures	   through	  
the	   synthesis-­‐dependent	   strand-­‐annealing	   (SDSA)	   pathway	   [124].	   In	   few	   cases,	  
strand	  exchange	  is	  followed	  by	  second-­‐end	  capture,	  DNA	  synthesis,	  and	  nick	  ligation	  







Figure	  14.	   Schematic	  of	   the	  homologous	   recombination	  DNA	  repair	  pathway.	  HR	  takes	  place	   in	  S	  and	  G2	  
phases	   of	   the	   cell	   cycle	   and	   repairs	   DSBs	   taking	   advantage	   of	   the	   intact	   sister	   chromatid	   (black)	   as	   a	  
template.	  The	  first	  step	  of	  the	  pathway	   is	  the	  5’-­‐>3’	  resection,	  which	  generates	  ssDNA	  tails.	  The	  resected	  
DNA	  ends	  are	  recombinogenic	  and	  invade	  the	  homologous	  template	  to	  form	  a	  displacement	  loop	  (D-­‐loop)	  
structure.	  After	  this	  process,	  DNA	  synthesis	  occurs.	  At	  this	  stage,	  the	  resulting	  D-­‐loop	  can	  be	  disrupted	  and	  
the	  displaced	  DNA	  can	  reanneal	  to	  the	  second	  DSB	  end,	  in	  a	  pathway	  known	  as	  synthesis-­‐dependent	  strand	  
annealing	   (SDSA),	   that	   yields	   non-­‐cross	   over	   products	   (NCOs).	   Sometimes,	   DNA	   synthesis	   is	   followed	   by	  
second-­‐end	  capture	  and	  nick	   ligation,	  generating	  double	  Holliday	  Junctions	  (dHJs).	  DHJs	  can	  be	  processed	  
to	  yield	  non-­‐crossover	  (NC)	  or	  crossover	  (CO)	  products,	  depending	  on	  the	  enzymes	  involved.	  [126]	  
	  
dHJs	   form	  a	   covalent	   linkage	  between	   two	   recombining	  DNA	  molecules,	   and	   their	  
removal	   is	   an	   essential	   step	   for	   a	   correct	   chromosome	   segregation.	   The	   enzymes	  
involved	  in	  processing	  these	  structures	  are	  highly	  specialized,	  and	  already	  described	  








3.7.1	  –	  Holliday	  Junction	  dissolution	  
	  
BLM	  has	  been	  shown	  to	  interact	  with	  Topoisomerase	  IIIα	  (TopoIIIα)	  and,	  along	  with	  
RMI1	   and	  RMI2,	   recruits	   and	   stimulates	   TopoIIIα	   activity	   on	  DNA	   [127].	   The	  BLM-­‐
TopoIIIα-­‐RMI1-­‐RMI2	  (BTRR)	  complex	  promotes	  the	  convergent	  branch	  migration	  of	  
a	  dHJ	  to	  form	  a	  hemicatenane	  that	  is	  a	  junction	  between	  two	  double-­‐stranded	  DNA	  
molecules,	   where	   a	   strand	   from	   one	   molecule	   winds	   around	   the	   complementary	  
strand	   from	   the	   other	   DNA	   molecule	   (Figure	   15).	   Hemicatenanes	   are	   afterwards	  
dissociated	  by	  the	  topoisomerase	  activity	  [128].	  The	  dissolution	  pathway	  yields	  only	  
NCO	  products	  (Figure	  16).	  COs	  are	  detrimental	  for	  somatic	  cells	  and	  the	  dissolution	  
pathway	   is	   required	   for	   avoidance	   of	   loss	   of	   heterozygosity	   (LOH)	   and	  
tumorigenesis.	   The	   BTRR	   complex	   is	   also	   responsible	   for	  DNA	   topology	   regulation	  
and	  resolves	  aberrant	  mitotic	  structures	  at	  centromeres	  [129].	  	  
	  
3.7.2	  –	  Holliday	  Junction	  resolution	  	  
	  
The	   HJ	   resolution	   pathway	   requires	   structure-­‐specific	   endonucleases,	   namely	  
MUS81-­‐EME1,	   SLX1-­‐SLX4	   and	   GEN1.	   GEN1	   cleaves	   HJs	   by	   generating	   symmetrical	  
nicks	   across	   the	   junction	   to	   produce	   nicked	   duplex	   intermediates.	   On	   the	   other	  
hand,	  MUS81-­‐EME1	  can	  cleave	  intact	  HJs	  with	  low	  efficiency,	  but	  it	  has	  high	  affinity	  
with	   3’-­‐flaps	   and	   replication	   forks	   (see	   chapter	   3.5).	   SLX1-­‐SLX4	   and	  MUS81-­‐EME1	  
cooperatively	   cleave	  HJs	   by	   a	   nick	   and	   counter-­‐nick	  mechanism.	   SLX4	   coordinates	  
the	  recruitment	  on	  the	  active	  sites	   in	  a	  manner	  that	  SLX1-­‐SLX4	  introduces	  the	  first	  
nick,	   producing	   an	  HJ-­‐intermediate	   that	   is	   further	   processed	   by	   the	  MUS81-­‐EME1	  
endonuclease	  [130].	  Unlike	  GEN1,	  the	  SLX-­‐MUS	  complex	  cleaves	  HJs	  asymmetrically,	  




resulting	  product	  contains	  short	  single-­‐stranded	  gaps	  and	  flaps	  that	  require	  further	  
processing	  before	  ligation	  [126].	  	  
	  
	  
Figure	  15.	   Illustration	  of	  the	  enzymes	   involved	   in	  HJ	  dissolution	  or	  resolution	  pathways.	  A)	  Dissolution	  by	  
the	  BTR	  complex.	  Left:	  domain	  structures	  of	  BLM,	  TopoIIIα,	  RMI1	  and	  RMI2.	  BTR-­‐proficient	  cells	  show	  low	  
level	  of	  sister	  chromatid	  exchanges	  (SCEs,	  right	  picture).	  3HB:	  3	  helix	  bundle;	  HRDC:	  helicase	  and	  RNase	  D	  
C-­‐terminal;	  NLS:	  nuclear	   localization	   signal;	  OB:	  oligonucleotide/oligosaccharide	  binding.	  B)	  Resolution	  by	  
SLX-­‐MUS	  complex.	  Left:	  domain	  structures	  of	  MUS81,	  EME1,	  SLX1	  and	  SLX4.	  HhH:	  helix-­‐hairpin-­‐helix;	  dark	  
and	   light	  grey	   indicate	  active	  and	   inactive	  motifs,	   respectively.	  Resolution	  pathway	   leads	   to	  NCO	  and	  CO	  
products,	  and	  SCEs	  (left	  picture).	  BTB:	  Bric-­‐a-­‐brac	  tramtrack	  broad	  complex;	  GIY:	  GIY-­‐YIG	  nuclease	  domain;	  
MLR:	   MUS312-­‐MEI9	   interaction-­‐like	   region;	   SAP:	   SAF-­‐A/B,	   Acinus,	   and	   PIAS;	   SBD,	   SLX1-­‐binding	   domain;	  
UBZ:	  ubiquitin-­‐binding	  zinc	  finger.	  C)	  Resolution	  by	  GEN1	  resolvase.	  Left)	  Domain	  structure	  of	  GEN1.	  X-­‐N,	  X-­‐
I:	   xeroderma	   pigmentosum	   complementation	   group	   G	   N-­‐terminal	   and	   internal	   nuclease	   domains.	   GEN1	  





3.8	  –	  Unresolved	  replication	  intermediates	  	  
	  
Faithful	  DNA	  replication	   is	  an	  essential	   step	   in	  order	   to	  maintain	  genome	   integrity	  
and	   to	   generate	   intact	   daughter	   cells.	   Although	   replication	   is	   a	   tightly	   regulated	  
process,	   it	   can	   be	   threaten	   by	   various	   kinds	   of	   impediments	   [131].	   Unresolved	  
problems	   arising	   from	   the	   S	   phase	   can	   affect	   chromosome	   segregation	   during	  
mitosis.	   Incompletely	   replicated	   loci	   and	   incompletely	   resolved	   intermediates	  
produced	  in	  S	  phase	  processes,	  such	  as	  DNA	  repair	  or	  recombination,	  can	  pass	  the	  
G2/M	   barrier	   and	   be	   directly	   carried	   into	   the	  M	   phase	   with	   under-­‐replicated,	   or	  
unresolved,	   chromosomes	   [132].	   Replication	   forks	   can	   stall	   especially	   in	   genome	  
regions	   where	   natural	   obstacles	   present	   on	   its	   way	   [133].	   Natural	   impediments,	  
such	   as	   unusual	   secondary	   structures,	   transcription	  machinery	   and	   late	   replicated	  
genome	   regions,	   generate	   additional	   challenges	   for	   the	   cell	   to	   maintain	   genomic	  
stability.	  	  
	   Despite	  the	  presence	  of	  checkpoint	  signaling	  that	   is	  activated	   following	  DNA	  
replication	   stress,	   there	   are	   genomic	   regions	   that	   escape	   this	   surveillance.	   This	   is	  
particular	   true	   for	   those	   regions	   that	   are	   late	   replicated,	   such	   as	   common	   fragile	  
sites,	   and	   intrinsically	   difficult	   to	   replicate	   regions,	   such	   as	   centromeres	   and	  
telomeres.	   Under-­‐replicated	   and/or	   unresolved	   DNA	   structures	   that	   are	   not	  
processed	  in	  S	  phase	  are	  inevitably	  carried	  over	  into	  mitosis.	  Although	  still	  unclear,	  it	  
seems	  that	  the	  cell	  has	  evolved	  a	  survival	  mechanism	  that	  allow	  it	  to	  minimize	  the	  
formation	   of	   aberrations	   and	   genomic	   instability	   during	   chromosome	   segregation.	  







3.8.1	  –	  Chromosomal	  fragility	  	  
	  
Replication	   stress	   can	   induce	   gaps	   and	   breaks,	   known	   as	   fragile	   sites,	   that	   are	  
cytogenetically	  visible	  on	  metaphase	  chromosomes	  [135].	  Fragile	  sites	  are	  inherited	  
by	   Mendelian	   genetics,	   and	   they	   can	   be	   mapped	   to	   specific	   chromosome	   arm	  
regions	  [136].	  Fragile	  sites	  are	  classified	  as	  common	  (present	   in	  all	   individuals)	  and	  
rare	  (present	  in	  less	  than	  5%	  of	  the	  population).	  Fragile	  sites	  are	  “expressed”	  when	  
they	  are	  visible	  on	  metaphase	  chromosomes	  and	  their	  frequency	  can	  be	  calculated.	  
Expression	  of	  fragile	  sites	  can	  be	  induced	  by	  different	  classes	  of	  replication	  inhibitors	  
(i.e.	   aphidicolin,	   folate,	   thymidylate)	   [133].	   Occurrence	   of	   fragile	   sites	   has	   been	  
linked	  with	  human	  diseases	  such	  as	  fragile	  X	  syndrome,	  a	  common	  heritable	  form	  of	  
mental	  retardation	  [137].	  	  
	   Rare	   fragile	  sites	  are	  caused	  by	  expansions	  of	   repetitive	  nucleotides	   (di-­‐	  and	  
trinucleotide	   microsatellites)	   and	   AT-­‐rich	   minisatellites	   extended	   at	   an	   abnormal	  
length,	   that	   are	   responsible	   for	   various	   diseases.	   At	   least	   80	   common	   fragile	   sites	  
have	   been	   described	   in	   the	   human	   genome	   and	   the	  most	   studied	   include	   3p14.2	  
(FRA3B),	  16q23	  (FRA16D),	  6q26	  (FRA6E),	  7q32.3	  (FRA7H)	  and	  Xp22.3	  (FRAXB)	  [133].	  
As	  already	  mentioned,	  common	  fragile	  sites	  are	  normal	  part	  of	  the	  DNA	  architecture	  
and	  characterized	  by	   long	  AT-­‐rich	  sequences	  and	  prone	  to	   formation	  of	  secondary	  
structures	  (i.e.	  hairpins).	  Interestingly,	  CFSs	  such	  as	  FRA3B	  and	  FRA16D	  overlap	  with	  
putative	  tumor-­‐suppressor	  genes,	  FHIT	  and	  WWOX,	  respectively.	  
	   Numerous	   aberrant	   DNA	   structures	   have	   been	   shown	   to	   be	   present	   within	  
CFSs,	   including	   stalled	   replication	   forks,	   persistent	   R-­‐loops	   and	   unresolved	  
replication	   intermediates.	   Recently,	   different	   labs	   revealed	   that	   CFS	   expression	  
involves	   an	   active	   mechanism	   rather	   than	   mechanical	   chromosome	   breakage	  
following	  chromatin	  condensation	  in	  mitosis	  [138,	  139].	  In	  these	  publications,	  it	  has	  




unresolved	   replication	   intermediates	  at	  CFSs	   coming	   from	  S	  phase	   in	  early	  mitosis	  
(Figure	   16).	   Absence	   of	   MUS81	   or	   ERCC1	   significantly	   increased	   frequency	   of	  
anaphase	  bridges,	  micronuclei	  formation	  and	  eventually	  caused	  53BP1	  nuclear	  body	  
accumulation	  in	  G1	  of	  the	  next	  cell	  cycle.	  	  
	   Taken	  together,	  these	  findings	  suggest	  that	  CFSs	  can	  represent	  a	  physiological	  
signal	  for	  replication	  termination,	  thus	  regulating	  the	  S-­‐M	  phase	  transition.	  In	  turn,	  
CFS	  expression	  is	  a	  required	  step	  to	  promote	  a	  correct	  chromosome	  segregation	  and	  
it	  explains	  the	  activation	  of	  specialized	  enzyme	  complexes	  for	  this	  processes	  at	  the	  
onset	  of	  mitosis.	  	  	  	  	  
	  
3.8.2	  –	  Centromeres	  
	  
Fragile	  sites	  are	  not	  the	  only	  genome	  hot	  spots	  where	  the	  replication	  machinery	  fails	  
to	   complete	   DNA	   synthesis	   due	   to	   formation	   of	   particular	   DNA	   structures.	  
Centromeres	  hold	  sister	  chromatids	  together	  and	  allow	  correct	  alignment	  on	  mitotic	  
spindles	   [140].	   Centromeric	   heterochromatin	   consists	   of	   repetitive	   elements,	   such	  
as	   α-­‐satellite	   DNA,	   and	   recombinatorial	   events	   can	   produce	   looped	   structures	   in	  
these	   regions	   [141].	   These	   structures	   can	   generate	   replication	   problems	   and	   in	  
yeast,	  centromeres	  are	  sites	  where	  the	  replication	   fork	  pauses	   [142],	  and	  they	  are	  
hot	  spots	  for	  chromosome	  breakage	  and	  rearrangements	  in	  mammals	  [143].	  	  
	   Among	  the	  unprocessed	  DNA	  structures	  that	  can	  persist	  at	  centromeres,	  the	  
double-­‐stranded	   DNA	   catenanes	   are	   the	   most	   common.	   Catenanes	   are	   fully	  
replicated	  and	  intertwined	  molecules	  generated	  as	  a	  consequence	  of	  the	  topological	  
stress	   during	   DNA	   replication,	   and	   they	   must	   be	   resolved	   before	   chromosome	  
segregation	   in	   anaphase	   [144].	   Since	   DNA	   topoisomerase	   IIα	   (TOPOIIα)	   performs	  
decatenation	   activity	   in	   humans	   [145],	   it	   can	   disentangle	   intertwined	   duplex	   DNA	  




from	   resolving	   catenanes	   on	   centromeres	   because	   cohesion	   proteins	   shield	   those	  
region,	  and	  only	  at	  the	  metaphase-­‐anaphase	  transition	  (when	  cohesins	  are	  cleaved)	  
can	  resolve	  these	  structures	  [146].	  	  
	   	  
	  
	  
Figure	   16.	   Schematic	   of	   S	   phase	   structures	   persisting	   in	   mitosis.	   i)	   Late	   replication	   intermediates	   that	  
escape	  MUS81-­‐EME1-­‐mediated	  cleavage	  are	  processed	  by	  the	  BTRR	  complex.	  The	  result	  of	  the	  dissolution	  
can	   generate	   ssDNA	   stretches	   that	   enter	   the	   mitotic	   phase.	   ii)	   dsDNA	   catenanes	   are	   resolved	   by	   the	  
TOPOIIα	   enzyme	   that	   decatenates	   the	   entanglement,	   forming	   two	   fully	   replicated	   double-­‐stranded	  
duplexes.	  iii	  and	  iv)	  MUS81-­‐EME1-­‐mediated	  resolution	  pathway	  is	  covered	  in	  the	  chapter	  3.5.	  v)	  RNA-­‐DNA	  
hybrids	  (R-­‐loops)	  are	  formed	  during	  the	  transcription	  process.	  Helicases	  can	  unwind	  R-­‐loops	  and	  the	  RNA	  












3.8.3	  –	  Telomeres	  
	  
Telomere	   regions	   are	   another	   category	   of	   hot	   spots	   where	   replication	   forks	  
frequently	  stall	  due	  to	  the	  presence	  of	  telomere-­‐binding	  proteins	  and	  G-­‐quadruplex	  
secondary	   structures	   forming	   in	   the	   G-­‐rich	   telomeric	   strand	   [147].	   Telomeres	   are	  
specialized	   structures,	   consisting	   of	   tandem	   repeats	   of	   TTAGGG	   nucleotides.	   They	  
cap	  the	  chromosome	  ends,	  and	  prevent	  chromosome	  end-­‐to-­‐end	  fusions	  and	   limit	  
the	   erosion	   caused	   by	   the	   end-­‐replication	   problem	  of	   DNA	   replication	   [148,	   149].	  
The	   frequent	   replication	   fork	   stalling	   at	   telomeres	   can	   lead	   to	   fork	   regression,	  
cleavage	  and	  collapse,	  and	  these	  regions	  are	  sensitive	  to	  replication	  stress,	  as	  much	  
as	  fragile	  sites	  are	  [150].	  Moreover,	  like	  common	  fragile	  sites,	  telomeres	  can	  behave	  
as	  sensors	  for	  genomic	  stress,	  since	  they	  can	  trigger	  the	  senescence	  pathway	  once	  
they	   reach	   a	   critical	   short	   length.	   Replication	   stress	   can	   induce	   an	   abnormal	   DNA	  
damage	  at	  telomeres	  that	  leads	  to	  telomere	  dysfunction-­‐induced	  senescence	  that	  is	  
independent	  from	  the	  telomere	  length	  [151].	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4.	  Aim	  of	  the	  study	  
	  
Chromosome	   segregation	  during	  mitosis	   is	   essential	   for	   correct	  distribution	  of	   the	  
genetic	   material	   to	   daughter	   cells.	   Common	   fragile	   sites	   (CFSs)	   are	   evolutionary	  
conserved	   loci	   that	  are	  replicated	  during	   late	  S-­‐phase	  and,	  recurrently,	  give	  rise	  to	  
gaps	  or	  breaks	  on	  metaphase	  chromosome	  spreads	  upon	  partial	   inhibition	  of	  DNA	  
synthesis,	   a	   phenomenon	   termed	   expression	   of	   CFSs.	  MUS81-­‐EME1	   endonuclease	  
has	  been	  shown	  to	  have	  an	  active	  role	  in	  CFS	  expression,	  promoting	  a	  correct	  sister	  
chromatid	   disjunction	   in	   anaphase.	   Previous	   studies	   in	   Janscak's	   and	   Krejci's	  
laboratories	   have	   shown	   that	   MUS81	   forms	   a	   stable	   complex	   with	   RECQ5	   DNA	  
helicase	  and	   that	  RECQ5	   stimulates	   cleavage	  of	   forked	  DNA	  structures	  by	  MUS81-­‐
EME1	   in	  vitro.	  The	  aim	  of	   this	   study	  was	   to	  explore	   the	  role	   for	  RECQ5	   in	  MUS81-­‐
mediated	  processing	  of	   late	   replication	   intermediates	  at	  CFSs	  during	  early	  mitosis.	  
By	  chromatin	  immunoprecipitation,	  we	  tested	  whether	  RECQ5	  associates	  with	  CFSs	  
in	   response	   to	   replication	   stress.	   By	   cytogenetic	   analysis,	   we	   tested	   the	   effect	   of	  
RECQ5	  depletion	  on	  CFS	  expression	  and	   the	   frequency	  of	  mitotic	  phenotypes	   that	  
arise	  due	  to	  chromosome	  segregation	  defects	  (e.g.	  anaphase	  bridges,	  micronuclei).	  
We	   also	   explored	   the	   possibility	   that	   RECQ5	   disrupts	   RAD51	   filaments	   formed	   on	  	  
stalled	   replication	   forks	   at	   CFSs,	   and	   hence	   facilitates	   MUS81-­‐EME1-­‐mediated	  
cleavage	   of	   these	   structures	   in	   mitosis.	   Finally,	   we	   have	   explored	   the	   functional	  
significance	   of	   mitosis-­‐specific	   phosphorylation	   of	   RECQ5	   at	   Ser727,	   which	   was	  
discovered	  in	  Janscak's	  laboratory.	  	  	  	  







5.1	  –	  Discovery	  of	  physical	  and	  functional	  interactions	  between	  MUS81-­EME1	  
endonuclease	  and	  RECQ5	  DNA	  helicase	  	  	  
	  
By	   coimmunoprecipitation,	   a	   former	   PhD	   student	   in	   our	   laboratory,	   Daniela	   Hühn	  
[152],	   discovered	   that	   MUS81	   exist	   in	   a	   complex	   with	   RECQ5	   in	   human	  
osteosarcoma	  U2OS	  cells	   (Figure	  17).	  Work	   conducted	  by	  Zdenka	  Hasanova	   in	   the	  
laboratory	  of	  Prof.	  Lumir	  Krejci	  have	  revealed	  that	  RECQ5	  binds	  to	  the	  MUS81-­‐EME1	  
complex	   in	   vitro.	   Specifically,	   using	   GST	   pull-­‐down	   assay,	   Zdenka	   Hasanova	   found	  
that	  RECQ5	  formed	  a	  tight	  complex	  with	  GST-­‐MUS81-­‐EME1	  in	  vitro	  [153].	  Moreover,	  
she	   observed	   a	   strong	   interaction	   between	   RECQ5	   and	   GST-­‐MUS81	   alone,	  
suggesting	   that	   on	   the	   MUS81-­‐EME1	   heterodimer,	   RECQ5	   binds	   to	   the	   MUS81	  
subunit	  [153].	  
	   Next,	   Zdenka	   Hasanova	   investigated	   whether	   RECQ5	   affects	   the	   nuclease	  
activity	   of	  MUS81-­‐EME1	   in	   vitro.	   MUS81-­‐EME1	   was	   shown	   to	   cleave	   a	   variety	   of	  
substrates	  with	  a	  preference	  towards	  3’-­‐flaps,	  replication	  forks	  and	  nicked	  Holliday	  
Junctions	  [154].	  Z.	  Hasanova	  demonstrated	  that	  RECQ5	  stimulated	  cleavage	  of	  these	  
DNA	  substrates	  by	  MUS81-­‐EME1	  irrespective	  of	  the	  presence	  of	  ATP	  [153].	  
	   These	  data	  suggest	  that	  RECQ5	  might	  promote	  cleavage	  of	  stalled	  replication	  




	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	   17.	  Physical	   interaction	   between	  MUS81	   and	   RECQ5.	   Immunoprecipitation	   (IP)	   of	   RECQ5	   from	   a	  
total	  extract	  of	  U2OS	  cells	  was	  performed	  using	  rabbit	  polyclonal	  antibodies	  against	  a	  C-­‐terminal	  (C-­‐term)	  
region	  of	  RECQ5	  (411-­‐991)	  or	  the	  full	  length	  (FL)	  RECQ5.	  IgG	  isolated	  from	  a	  preimmune	  serum	  was	  used	  in	  
control.	   Immunoprecipitates	   were	   analyzed	   by	   immunoblotting	   (IB)	   using	   indicated	   antibodies.	   Where	  
indicated,	  extracts	  were	  supplemented	  with	  ethidium	  bromide	  (EtBr)	  to	  disrupt	  DNA-­‐protein	  interactions.	  
	  
5.2	  –	  RECQ5	  is	  actively	  involved	  in	  expression	  of	  common	  fragile	  sites	  
	  
MUS81-­‐EME1	   promotes	   CFS	   expression	   by	   cleaving	   replication	   intermediates	   at	  
these	  loci	  in	  early	  mitosis,	  facilitating	  correct	  chromosome	  segregation.	  As	  we	  found	  
that	  MUS81-­‐EME1	   interacts	  physically	  and	  functionally	  with	  RECQ5,	  we	  thought	  to	  
test	  whether	  RECQ5	  is	  required	  for	  expression	  of	  CFSs.	  CFS	  expression	  is	  assessed	  by	  
quantification	   of	   chromatid	   breaks/gaps	   on	   metaphase	   chromosome	   spreads.	  
Depletion	   of	   MUS81	   from	   cells	   was	   shown	   to	   inhibit	   chromatid	   break	   formation	  
induced	   by	  mild	   replication	   stress	   generated	   by	   exposure	   of	   cells	   to	   low	  doses	   of	  
aphidicolin	  [138].	  It	  has	  been	  estimated	  that	  aphidicolin	  promotes	  expression	  of	  84	  
out	   of	   89	   common	   fragile	   sites	   [155].	   We	   performed	   metaphase	   chromosome	  
spread	   analysis	   of	  U2OS	   cells	   depleted	   of	   RECQ5,	  MUS81	   or	   both.	  We	   found	   that	  




extent	   as	  MUS81	   depletion.	   Simultaneous	   down-­‐regulation	   of	   RECQ5	   and	  MUS81	  
did	   not	   further	   decrease	   the	   frequency	   of	   CFS	   breakage,	   suggesting	   that	   the	   two	  
proteins	   work	   in	   the	   same	   pathway	   (Figure	   18).
	   The	  finding	  that	  RECQ5	  is	  involved	  in	  CFS	  expression	  prompted	  us	  to	  examine	  
whether	   it	   physically	   interacts	   with	   CFS	   regions.	   Chromatin	   immunoprecipitation	  
(ChIP)	   is	  a	  powerful	   technique	   to	  study	  chromatin-­‐protein	   interactions,	  even	   if	   the	  
protein	   of	   interest	   is	   not	   directly	   bound	   to	   the	   DNA.	   Formaldehyde	   cross-­‐linked	  
chromatin	   fractions	   from	  U2OS	   cells	   treated	   or	   not	  with	   0.2	   μM	   aphidicolin	  were	  
sonicated	   and	   immunoprecipitated	   with	   antibodies	   against	   RECQ5	   or	   MUS81.
The	   immunoprecipitates	   were	   subjected	   to	   quantitative	   real-­‐time	   PCR	   (qPCR)	  
analysis	  using	  primers	  specific	   to	   three	  different	  CFSs,	  namely	  FRA3B,	  FRA16D	  and	  
FRA7H.	  Primers	  for	  GAPDH	  locus	  were	  used	  as	  control.	  We	  found	  that	  both	  RECQ5	  
and	  MUS81	   were	   significantly	   enriched	   at	   all	   three	   CFSs	   as	   compared	   to	   GAPDH	  
locus.	  Moreover,	  replication	  stress	  considerably	  enhanced	  the	  binding	  of	  RECQ5	  and	  
MUS81	  to	  CFS	  loci,	  but	  not	  to	  the	  GAPDH	  locus	  (Figure	  19).	  	  
	   To	  test	  whether	  MUS81	  and	  RECQ5	  associate	  with	  CFS	  chromatin	   in	  mitosis,	  
we	   treated	   U2OS	   cells	   with	   a	   selective	   CDK1	   inhibitor,	   RO-­‐3306.	   CDK1/cyclin	   B	  
complex	   regulates	   the	   G2/M	   transition,	   therefore,	   RO-­‐3306	   is	   commonly	   used	   to	  
synchronize	  proliferating	  cells	  in	  late	  G2	  phase	  [156].	  	  After	  exposure	  of	  cells	  to	  RO-­‐
3306	   in	   the	   absence	   (DMSO)	   or	   the	   presence	   of	   aphidicolin,	   we	   performed	   ChIP	  
assay	   using	   antibodies	   against	   RECQ5	   and	   MUS81.	   We	   again	   analyzed	   the	  
immunoprecipitated	   material	   by	   qPCR	   for	   the	   presence	   of	   CFS	   regions	   (FRA3B,	  
FRA16D	   and	   FRA7H).	   The	   results	   showed	   that	   if	   entry	   into	  mitosis	   was	   inhibited,	  
MUS81	  and	  RECQ5	  were	  no	  longer	  recruited	  to	  CFSs.	  (Figure	  19).	  We	  conclude	  that	  





Figure	   18.	  RECQ5	  promotes	   expression	   of	   common	   fragile	   sites.	   a)	  U2OS	   cells	  were	   depleted	   of	   RECQ5	  
and/or	   MUS81	   and	   then	   treated	   with	   0.2	   μM	   aphidicolin	   for	   24	   h.	   Nocodazole	   was	   added	   at	   a	  
concentration	   of	   200	   ng/mL	   for	   the	   last	   5	   h	   in	   order	   to	   enrich	   mitotic	   population.	   Mitotic	   cells	   were	  
harvested	   and	   swollen	   in	   hypotonic	   solution	   before	  methanol-­‐acetic	   acid	   fixation.	  Metaphase	   cells	  were	  
spread	  and	  visible	  chromatid	  breaks	  were	  counted.	  Two	  different	  siRNAs	  for	  RECQ5	  depletion	  were	  used.	  
At	   least	   100	   spreads	   were	   analyzed	   in	   three	   independent	   experiments.	   Error	   bars	   show	   S.D.	   b)	  
Representative	   image	  of	   intact	  and	  broken	  chromatids.	  c)	  Western-­‐blot	  analysis	  showing	  the	  efficiency	  of	  







	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  
Figure	  19.	  RECQ5	  and	  MUS81	  bind	  to	  CFSs	  upon	  entry	  into	  mitosis.	  Chromatin	  immunoprecipitation	  (ChIP)	  
of	  RECQ5	  or	  MUS81	  was	  performed	  after	  treatment	  of	  cells	  with	  0.2	  μM	  aphidicolin	  or	  DMSO	  (control)	  for	  
24h.	   Were	   indicated,	   9	   μM	   RO-­‐3306	   was	   added	   together	   with	   aphidicolin/DMSO.	   Immuno-­‐precipitated	  
DNA	  was	  analyzed	  by	  qPCR,	  using	  primer	  pairs	  for	  three	  different	  CFSs	  (FRA3B,	  FRA16D,	  FRA7H)	  and	  GAPDH	  
as	  control.	  Data	  are	  the	  mean	  of	  three	  independent	  experiments.	  Error	  bars	  show	  S.D.	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	   	  
Figure	   20.	   Effect	   of	   RECQ5	   depletion	   on	   MUS81	   binding	   to	   CFSs.	   Cross-­‐linked	   chromatin	   of	   mock-­‐	   or	  
RECQ5-­‐depleted	   U2OS	   cells	   treated	   or	   not	   (DMSO)	   with	   0.2	   μM	   aphidicolin	   for	   24	   h	  was	   subjected	   to	  
immunoprecipitation	   with	   MUS81	   antibody	   followed	   by	   qPCR	   analysis.	   FRA3B,	   FRA16D	   and	   FRA7H	   loci	  
were	  used	  as	  representative	  regions	  for	  CFSs	  and	  GAPDH	  as	  a	  negative	  control.	  Data	  are	  the	  mean	  of	  three	  





MUS81-­‐EME1	  was	  proposed	  to	  actively	  cleave	  fork-­‐like	  structures	  persisting	  at	  CFSs	  
during	  early	  mitosis	   [138].	  Therefore,	  we	  reasoned	  that	  the	  binding	  of	  MUS81	  and	  
RECQ5	  on	  CFSs	   revealed	  by	  ChIP	   (Figure	  20)	  occurred	  at	   the	  G2/M	  transition	  or	   in	  
prophase/pro-­‐metaphase.	   Indeed,	  by	   immunofluorescence,	   it	  has	  been	  shown	  that	  
MUS81	  accumulates	  on	  CFSs	  (marked	  by	  FANCD2	  foci)	  at	  the	  onset	  of	  mitosis	  until	  
metaphase	  [138].	  	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	  21.	  MUS81	  is	  required	  for	  RECQ5	  recruitment	  on	  CFSs.	  RECQ5	  ChIP	  in	  MUS81-­‐depleted	  U2OS	  cells	  
in	  presence	  or	  absence	  of	   replication	   stress.	   Fold	  enrichment	  of	  RECQ5	  binding	  on	  CFSs	   (FRA3B,	  FRA16D	  
and	   FRA7H)	   and	   one	   control	   gene	   (GAPDH)	   was	   calculated	   by	   qPCR.	   Data	   represent	   the	   mean	   of	   3	  
independent	  experiments.	  Error	  bars	  show	  S.D.	  	  	  
	   	  
	   We	  next	  analyzed	  association	  of	  RECQ5	  with	  CFSs	  in	  cells	  depleted	  of	  MUS81.	  
Interestingly,	   we	   found	   that	  MUS81	   depletion	   abrogated	   binding	   of	   RECQ5	   to	   all	  
three	  CFSs	   tested	  both	   in	   the	  absence	  and	   the	  presence	  of	  aphidicolin,	  suggesting	  
that	  MUS81	  might	  mediate	  RECQ5	  recruitment	  to	  CFSs	  (Figure	  21).	  On	  the	  contrary,	  
depletion	  of	  RECQ5	  caused	  a	  small	  enrichment	  of	  MUS81	  on	  CFSs.	  This	  might	  reflect	  
the	  defect	  in	  CFS	  breakage	  observed	  in	  RECQ5-­‐deficient	  cells	  and	  implies	  that	  RECQ5	  
is	  not	  involved	  in	  MUS81	  recruitment	  to	  CFSs.	  
	   Together,	   these	  data	   suggests	   that	  RECQ5	   is	   actively	   involved	   in	   cleavage	  of	  




5.3	  –	  RECQ5	  promotes	  correct	  chromosome	  segregation	  during	  anaphase	  
	  
We	   further	   investigated	   whether	   RECQ5	   acts	   in	   concert	   with	  MUS81	   to	   promote	  
correct	  sister	  chromatid	  disjunction	  by	  resolving	  replication	  intermediates	  persisting	  
on	   CFSs.	   Unresolved	   replication	   intermediates	   that	   persist	   through	   mitosis	   are	  
converted	  into	  DNA	  lesions	  and,	  in	  the	  next	  G1	  phase	  of	  the	  cell	  cycle,	  daughter	  cells	  
show	  accumulation	  of	  53BP1	  nuclear	  bodies	  that	  are	  thought	  to	  shield	  DNA	  lesions	  
until	  repair	  mechanisms	  are	  available	  again	  in	  G1/S	  [134].	  Depletion	  of	  MUS81	  was	  
shown	   to	   increase	   the	   frequency	   of	   53BP1	   nuclear	   bodies	   in	   G1	   cells	   [138].	   We	  
therefore	   depleted	   RECQ5	   or	   MUS81	   (as	   positive	   control)	   from	   U2OS	   cells	   and	  
analyzed	   53BP1	   nuclear	   body	   frequency	   in	   G1	   cells	   by	   immunofluorescence.	   To	  
distinguish	   G1	   cells,	   we	   used	   a	   cyclin	   A	   antibody	   to	   stain	   replicating	   cells	   and	  
counted	   the	   number	   of	   53BP1	   nuclear	   bodies	   in	   cyclinA-­‐negative	   cells.	   Notably,	  
RECQ5	  depletion	  caused	  53BP1	  nuclear	  body	  accumulation	   in	  G1	  cells	   (>	  3	  nuclear	  
bodies	   of	   53BP1),	   and	   double-­‐depletion	   of	   RECQ5	   and	  MUS81	   brought	   about	   the	  
same	   frequency	   of	   cyclinA-­‐negative	   cells	   with	   53BP1	   nuclear	   bodies	   as	   single	  
depletions	  	  (Figure	  22).	  	  
	   Next,	   we	   wanted	   to	   determine	   whether	   depletion	   of	   RECQ5	   caused	  
accumulation	  of	  53BP1	  nuclear	  bodies	  at	  CFSs.	  To	  this	  end,	  we	  performed	  ChIP	  assay	  
for	  53BP1	  using	  cells	  depleted	  of	  RECQ5,	  MUS81	  or	  both.	  	  Cells	  were	  exposed	  to	  low	  
doses	   of	   aphidicolin	   for	   16	   h	   or	   left	   untreated.	   As	   expected,	   aphidicolin	   induced	  
53BP1	  accumulation	  on	  CFSs	  and	  not	  on	   the	  GAPDH	  gene.	  Depletion	  of	  RECQ5	  or	  






Figure	   22.	   Depletion	   of	   RECQ5	   leads	   to	   accumulation	   of	   53BP1	   nuclear	   bodies	   in	   G1	   cells.	   a)	  
Representative	   images	   of	   53BP1	   nuclear	   bodies	   in	   cyclinA-­‐negative	   cells	   depleted	   for	   indicated	   proteins.	  
Green	  staining	   is	   for	  53BP1,	   red	   for	   cyclinA	  and	  blue	  DAPI.	  b)	  Quantification	  of	   the	   frequency	  of	   cyclinA-­‐
negative	  cells	  that	  have	  more	  than	  three	  nuclear	  bodies	  (n.b.).	  Two	  different	  siRNAs	  for	  RECQ5	  depletion	  
were	  used.	  The	  data	  represent	  the	  mean	  of	  4	  independent	  experiments.	  Error	  bars	  show	  S.D.	  At	  least	  600	  
cyclin	  A-­‐negative	  cells	  were	  scored	  for	  each	  condition.	  
	  
Importantly,	  simultaneous	  knockdown	  of	  RECQ5	  and	  MUS81	  has	  no	  additive	  effect	  
in	  comparison	  with	  knockdown	  of	  either	  protein,	  suggesting	  that	  RECQ5	  and	  MUS81	  




Figure	  23.	  RECQ5	  depletion	  promotes	  53BP1	  and	  γ-­‐H2AX	  accumulation	  on	  CFSs.	  Mock-­‐,	  RECQ5-­‐,	  MUS81-­‐	  
and	  RECQ5/MUS81-­‐depleted	  U2OS	  cells	  were	  grown	  with	  or	  without	  (DMSO)	  0.2	  μM	  aphidicolin	  for	  24	  h.	  
Cross-­‐linked	  chromatin	  of	  these	  cells	  was	  subjected	  to	  ChIP	  assay	  using	  53BP1	  (a)	  or	  γ-­‐H2AX	  (b)	  antibodies.	  
Immuno-­‐precipitated	   DNA	   was	   analyzed	   by	   qPCR,	   using	   primer	   pairs	   for	   three	   different	   CFSs	   (FRA3B,	  
FRA16D,	  FRA7H)	  and	  GAPDH	  as	  control	  .	  Data	  represent	  the	  mean	  of	  three	  independent	  experiments.	  Error	  
bars	  show	  S.D.	  
	  
	   In	   addition	   to	   53BP1,	   we	   looked	   at	   another	   DNA	   damage	   marker,	   the	  




known	   to	   be	   a	   marker	   for	   the	   presence	   of	   replication	   stress.	   By	   ChIP	   assay,	   we	  
analyzed	  the	  levels	  of	  γ-­‐H2AX	  on	  CFSs	  following	  the	  same	  conditions	  as	  those	  used	  
in	   53BP1	   ChIP	   experiments.	   We	   observed	   that	   depletion	   of	   RECQ5	   or	   MUS81	  
increased	   γ-­‐H2AX	   levels	   at	   CFSs	   in	   both	   non-­‐treated	   and	   aphidicolin-­‐treated	   cells,	  
and	  the	  combination	  of	  RECQ5	  or	  MUS81	  depletions	  did	  not	  have	  additive	  effect	  in	  
comparison	  with	  depletion	  of	  either	  protein	  	  (Figure	  23).	  	   	  
	   Unresolved	   replication	   intermediates	   generate	   well-­‐characterized	   mitotic	  
phenotypes	   that	   can	   be	   observed	   by	   standard	   immunofluorescence	   techniques.	  
First,	   bulky	   DNA	   bridges	   can	   form	   during	   anaphase	   as	   a	   result	   of	   aberrant	  
chromosome	  morphology	  or	  defects	  in	  the	  mitotic	  machinery	  [132].	  Bulky	  anaphase	  
bridges	   can	   be	   visualized	   by	   staining	   with	   DNA-­‐intercalating	   dyes	   such	   as	   DAPI.	  
MUS81	  depletion	  increases	  bulky	  anaphase	  bridges	  as	  result	  of	  failure	  in	  resolution	  
of	   replication	   intermediates	   [138].	   Therefore,	  we	   asked	  whether	   RECQ5	  depletion	  
led	   to	   the	   same	   phenotype.	   We	   depleted	   RECQ5	   in	   U2OS	   cells	   and	   scored	   the	  
frequency	   of	   anaphase	   cells	   that	   showed	   one	   or	  more	   DAPI-­‐positive	   bridges.	  We	  
found	  that	  RECQ5	  depletion	  increased	  anaphase	  bridge	  frequency	  to	  nearly	  30%	  of	  
the	   anaphase	   cells	   analyzed,	   whereas	   mock-­‐depleted	   cells	   showed	   an	   anaphase	  
bridge	   frequency	   of	   about	   10%.	   MUS81	   depletion	   increased	   anaphase	   bridge	  
frequency	  to	  a	  level	  comparable	  with	  RECQ5	  depletion.	   	   Importantly,	  simultaneous	  
depletion	   of	   RECQ5	   and	   MUS81	   led	   to	   the	   same	   frequency	   of	   anaphase	   bridge	  
formation	  as	  MUS81	  or	  RECQ5	  depletions,	   again	   confirming	   that	   the	   two	  proteins	  





	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure	   24.	   RECQ5	   depletion	   causes	   the	   formation	   of	   bulky	   anaphase	   DNA	   bridges.	   a)	   Representative	  
image	   of	   control	   anaphase	   cells	   and	  DAPI-­‐positive	   DNA	   bridges	   in	   RECQ5-­‐depleted	   cells.	  b)	  Quantitative	  
analysis	   of	   the	   frequency	   of	   bulky	   anaphase	   bridges.	   RECQ5	   or	  MUS81	   were	   depleted	   of	   U2OS	   cells	   as	  
indicated.	   After	   formaldehyde	   fixation,	   cells	   were	   stained	   with	   DAPI.	   Percentage	   of	   anaphase	   cells	   with	  
DAPI-­‐positive	  bridges	  was	  calculated	  for	  each	  condition.	  The	  data	  represent	  the	  mean	  of	  two	  independent	  
experiments.	  Error	  bars	  show	  S.D.	  At	  least	  150	  anaphase	  cells	  were	  analyzed.	  
	  
	  
	   An	   additional,	   well	   characterized,	   category	   of	   anaphase	   bridges	   are	   the	   so-­‐
called	  ultrafine	  bridges	   (UFBs).	  This	  particular	  class	  of	  mitotic	  structures	  cannot	  be	  
stained	   with	   classical	   DAPI	   dyes.	   Instead,	   UFBs	   could	   be	   visualized	   by	  
immunofluorescence	   staining	   using	   BLM	   or	   PICH	   (Polo-­‐like	   kinase	   1	   interacting	  
checkpoint	   helicase)	   antibodies	   [157].	   It	   has	   been	   shown	   that	   UFBs	   are	   formed	  
naturally	   and	   are	   resolved	   by	   the	   BLM	   pathway	   [158].	   The	   frequency	   of	   UFBs	   is	  
dramatically	   increased	   upon	   treatment	   of	   cells	  with	   low	  doses	   of	   aphidicolin,	   and	  
MUS81	  depletion	  increases	  UFB	  formation	  at	  CFSs	  in	  aphidicolin-­‐treated	  cells	  [138].	  
Therefore,	  we	  wanted	  to	  check	  whether	  down-­‐regulation	  of	  RECQ5	  had	  an	  effect	  on	  




MUS81,	   and	   determined	   the	   percentage	   of	   anaphase	   cells	   showing	   one	   or	   more	  
PICH-­‐positive	  bridges.	  Interestingly,	  we	  observed	  that	  the	  frequency	  of	  UFB	  bridges	  
increased	  by	  about	  2-­‐fold	   if	   cells	  were	  depleted	  of	  RECQ5	  or	  MUS81	   (siCtrl:	   8.4%,	  
siRECQ5#1:	   15.5%,	   siMUS81:	   13.6%;	   Figure	   25).	   Simultaneous	   depletion	   of	   RECQ5	  
and	  MUS81	   did	   not	   lead	   to	   a	   further	   increase	   in	   UFB	   frequency	   as	   compared	   to	  
depletion	   of	   either	   protein,	   indicating	   that	   RECQ5	   and	   MUS81	   act	   in	   the	   same	  
pathway	  to	  suppress	  the	  formation	  of	  UFB	  bridges.	  	  
	  
Figure	  25.	  Depletions	  of	  RECQ5	  or	  MUS81	  increase	  the	  frequency	  of	  PICH-­‐positive	  UFBs.	  U2OS	  cells	  were	  
depleted	  of	  RECQ5	  or	  MUS81	  for	  72	  h,	  and	  RO-­‐3306	  was	  added	  for	  the	  last	  16	  h	  to	  block	  the	  cells	  at	  G2/M.	  
Cells	  were	   then	   released	   from	  RO-­‐3306	   for	   1.5	   h	   and	   fixed/permeabilized	   in	   PTEM	  buffer	   for	   15	  min.	  a)	  
Representative	   images	  of	  PICH-­‐positive	  UFBs.	  An	  antibody	  against	  PICH	  was	  used	   in	  order	  to	  detect	  UFBs	  
(red),	  and	  DAPI	  stained	  DNA	  (light	  grey).	  b)	  Quantitative	  analysis	  of	  UFB	  frequency	  in	  U2OS	  cells	  transfected	  
with	  indicated	  siRNA.	  Data	  represent	  the	  mean	  of	  three	  independent	  experiments.	  Error	  bars	  show	  S.D.	  At	  
least	  120	  anaphase	  cells	  were	  analyzed	  for	  each	  condition.	  
	  
	   A	   third	   phenotype	   associated	  with	   incorrect	   chromosome	   disjunction	   is	   the	  
formation	   of	   micronuclei.	   Micronuclei	   are	   small	   extranuclear	   bodies	   consisting	   of	  




instability.	  They	  are	  formed	  upon	  treatment	  of	  cells	  with	  DNA-­‐damaging	  chemicals	  
or	   radiation,	   and	  are	   also	  observed	   in	   cancer	   cells	   [159,	   160].	  We	  determined	   the	  
frequency	   of	  micronuclei	   in	   RECQ5-­‐	   and	  MUS81-­‐depleted	  U2OS	   cells.	   To	   this	   end,	  
cells	  were	  blocked	   from	  entering	  cytokinesis	  by	   the	  addition	  of	  cytochalasin	  B	  and	  
the	   percentage	   of	   binucleated	   cells	   having	   micronuclei	   was	   determined	   for	   each	  
condition.	  We	  found	  that	  MUS81	  depletion	  increased	  the	  frequency	  of	  micronuclei	  
formation	  as	  previously	  reported	  [138].	  An	  increased	  frequency	  of	  micronuclei	  was	  
also	   observed	   in	   RECQ5-­‐depleted	   cells.	   Simultaneous	   depletion	   of	   RECQ5	   and	  
MUS81	   did	   not	   further	   increase	   the	   frequency	   of	   micronuclei	   appearance	   as	  
compared	  to	  depletion	  of	  either	  protein	  (Figure	  26).	  	  	  
	  
Figure	  26.	  Frequency	  of	  micronuclei	  formation	  increases	  upon	  RECQ5	  depletion.	  a)	  Representative	  image	  
of	  mock-­‐	  and	  RECQ5-­‐depleted	  U2OS	  cells	  blocked	  in	  cytokinesis.	  RECQ5-­‐depleted	  cells	  possess	  micronuclei	  
(red	   arrows).	   b)	   Quantitative	   analysis	   of	   the	   formation	   of	   micronuclei	   in	   U2OS	   cells	   transfected	   with	  
indicated	   siRNAs.	   Cells	   were	   incubated	   with	   0.2	   μM	   cytochalasin	   B	   for	   16	   h	   before	   fixation	   with	  
formaldehyde	   and	   DAPI	   staining.	   Only	   cytokinesis-­‐blocked	   cells	   were	   taken	   into	   consideration	   for	  
micronuclei	   quantification.	   The	   data	   represent	   the	   mean	   of	   three	   independent	   experiments.	   Error	   bars	  





	   Taken	   together	   these	   data	   suggest	   a	   role	   for	   RECQ5	   in	   promoting	   sister	  
chromatid	   separation	   to	  avoid	  genome	   instability	   in	  daughter	  cells.	  Moreover,	  our	  
data	  suggest	  that	  RECQ5	  works	   in	  the	  same	  pathway	  as	  MUS81	  and	  are	  consistent	  
with	  our	  earlier	   findings	   suggesting	   that	  RECQ5	  acts	   to	  promote	  MUS81-­‐mediated	  
cleavage	  of	  late	  replication	  intermediates	  at	  CFSs	  in	  early	  mitosis.	  	  	  	  	  
	  
5.4	  –	  Discovery	  of	  a	  novel	  RECQ5	  phosphorylation	  site	  and	  its	  role	  in	  mitosis	  
	  
A	   previous	  Master	   student	   in	  our	   laboratory,	   Jana	   Langhoff,	   observed	   that	  RECQ5	  
immunoprecipitated	   from	   cells	   synchronized	   in	   prometaphase	   by	   nocodazole	  
treatment	   displayed	   a	   reduced	   electrophoretic	   mobility	   as	   compared	   to	   RECQ5	  
immunoprecipitated	  from	  non-­‐synchronized	  cells.	  Treatment	  of	  immunoprecipitates	  
with	   λ	   phosphatase	   abolished	   the	   RECQ5	   band	   shift,	   suggesting	   a	   possible	  
phosphorylation	  of	  RECQ5	  in	  early	  mitosis.	  In	  collaboration	  with	  Stefano	  Ferrari	  lab,	  
Jana	  Langhoff	  set	  up	  a	  kinase	  assay	  in	  which	  she	  incubated	  the	  full-­‐length	  RECQ5	  (1-­‐
991)	  or	  a	  RECQ5	  truncated	  version	  spanning	  amino	  acids	  1-­‐725	  with	  the	  CDK1/CycB1	  
complex	   and	   [γ-­‐32P]ATP.	   She	   observed	   that	   wild-­‐type	   RECQ5	   was	   extensively	  
phosphorylated	  by	  CDK1/CycB1	  under	  these	  conditions,	  while	  the	  truncated	  RECQ5	  
was	   not	   [161].	   	   From	   the	   PhosphoSitePlus®	   (www.phosphosite.org)	   database,	   it	   is	  
evident	   that	   two	   phosphorylation	   sites	   identified	   in	   human	   RECQ5	   by	   mass	  
spectrometry	   are	   part	   of	   the	   CDK	   consensus	   motif	   (S/T-­‐P-­‐X-­‐R/K):	   Ser727	  
(SAHYGGPsPEKKAKS)	   and	   Thr845	   (PEVQPtPAKDTWK,	   Figure	   27).	   By	   site-­‐directed	  
mutagenesis,	   Jana	  Langhoff	   found	   that	  alanine	  substitutions	  at	   these	   two	  residues	  







Figure	  27.	  Print	  screen	  from	  the	  PhosphoSitePlus	  database	  of	  the	  putative	  RECQ5	  phosphorylation	  sites.	  
The	  scale	  bar	  represents	  the	  a.a.	  length	  of	  RECQ5.	  	  	  
	  
	   To	  assess	  whether	  these	  residues	  are	  the	  targets	  of	  RECQ5	  phosphorylation	  in	  
mitosis,	  Jana	  Langhoff	  generated	  corresponding	  single	  and	  double-­‐mutants	  mutants	  
of	  Flag-­‐tagged	  RECQ5	  and	  tested	  whether	  these	  mutants,	  after	  transient	  expression	  
in	   HeLa	   cells,	   display	   a	   shift	   in	   electrophoretic	   mobility	   if	   cells	   are	   subjected	   to	  
nocodazole	   treatment.	   She	   found	   that	   RECQ5	   shift	   was	   abolished	   by	   Ser727Ala	  
mutation,	  suggesting	  that	  RECQ5	  phosphorylation	  in	  early	  mitosis	  occurs	  at	  Ser727	  
[161].	  
	   These	   findings	   prompted	   us	   to	   investigate	   the	   biological	   role	   of	   RECQ5	  
phosphorylation	  at	  Ser727.	  First,	  we	  raised	  a	  rabbit	  polyclonal	  antibody	  against	  the	  
phospho-­‐Ser727	   epitope.	   Using	   this	   antibody,	   we	   could	   confirm	   that	   RECQ5	  
phosphorylation	  at	  Ser727	  was	  dramatically	   increased	  upon	  nocodazole	   treatment	  
(Figure	   27,	   lane	   1	   and	   2).	   Moreover,	   we	   found	   that	   if	   cells	   were	   released	   from	  
nocodazole	  block,	  the	  phosphorylated	  form	  of	  RECQ5	  disappeared,	  suggesting	  that	  
RECQ5	   is	   dephosphorylated	  with	   the	   onset	   of	   anaphase	   (Figure	   28,	   lane	   3).	   From	  
this	   experiment,	   we	   propose	   that	   RECQ5	   phosphorylation	   occurs	   in	   early	  mitosis,	  





	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	  28.	  RECQ5	  is	  phosphorylated	  at	  Ser727	  in	  early	  mitosis.	  U2OS	  cells	  were	  treated	  with	  nocodazole	  
for	  16	  h,	  and,	  eventually,	  released	  into	  fresh	  DMEM	  medium	  for	  1	  or	  5	  h.	  Total	  cell	  extracts	  were	  analyzed	  
by	  western	  blotting.	  Blots	  were	  probed	  with	  antibody	  against	  the	  phospho-­‐Ser727	  epitope.	  TFIIH	  was	  used	  
as	   loading	  control.	  Antibody	  raised	  against	   the	  full-­‐length	  RECQ5	  was	  used	  for	  monitoring	  RECQ5	  protein	  
levels.	  Mitosis	  was	  monitored	  by	  H3	  phosphorylation	  at	  Ser10.	  	  	  
	  
	   We	  prepared	  U2OS	  T-­‐REx	  cell	   lines	  that	  express	  Flag-­‐tagged	  versions	  of	  wild-­‐
type	   RECQ5	   or	   its	   S727A	   mutant	   under	   control	   of	   a	   doxycyclin-­‐regulated	   CMV	  
promoter	  in	  the	  pAIO	  vector	  [162]	  (Figure	  29).	  We	  took	  advantage	  of	  this	  inducible	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	  29.	  Schematic	  of	  the	  inducible	  system	  for	  expression	  of	  wild-­‐type	  and	  mutant	  forms	  of	  RECQ5-­‐Flag	  
fusion	  protein	  in	  U2OS-­‐T-­‐REx	  cells.	  RECQ5	  ORF	  is	  cloned	  under	  the	  control	  of	  a	  CMV	  promoter	  containing	  
two	  copies	  of	  the	  tet	  operator	  (TetO2)	  sequence.	  Tet	  repressor,	  which	  is	  constitutively	  expressed	  in	  U2OS-­‐
T-­‐REx	   cells,	   binds	   to	   the	   tet	   operator	   sequence	   and	   blocks	   expression	   of	   the	   RECQ5	   transgene.	   Upon	  
addition	  of	  doxycyclin,	  the	  expression	  of	  RECQ5	  transgene	  is	  induced.	  RECQ5-­‐Flag	  transcript	  is	  resistant	  to	  





cellular	   system	   to	   explore	   the	   role	   of	   RECQ5	   phosphorylation	   in	   the	   function	   of	  
RECQ5	   during	  mitosis,	   since	   we	   obtained	   evidence	   that	   RECQ5	   is	   involved	   in	   CFS	  
expression	   (see	   chapter	   5.3).	   First,	   we	   wanted	   to	   test	   whether	   RECQ5	  
phosphorylation	   at	   Ser727	   was	   required	   for	   the	   appearance	   of	   chromatid	  
breaks/gaps	  on	  metaphase	  chromosomes	  upon	  replication	  stress.	  We	  depleted	  the	  
endogenous	   RECQ5	   with	   siRNA	   to	   which	   the	   ectopically	   expressed	   RECQ5	   was	  
resistant.	   To	   induce	   the	   expression	   of	   RECQ5	   transgene	   in	   these	   cells	   lines,	  
doxycyclin	  was	   added	   at	   24	   h	   after	   siRNA	   transfection	   and	   cells	  were	   cultures	   for	  
additional	  48	  h.	  Western	  blot	  analysis	  of	  wild-­‐type	  or	  S727A	  samples	   showed	   that	  
under	   conditions	  used,	   endogenous	  RECQ5	  and	  FLAG-­‐tagged	  RECQ5	  protein	   levels	  
were	  nearly	  comparable	  (Figure	  30;	  see	  RECQ5	  blots,	  compare	  lanes	  1	  and	  3).	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	  30.	  Western	  blot	  analysis	  of	  expression	  of	  wild-­‐type	  and	  S727A	  forms	  of	  RECQ5-­‐Flag	  in	  U2OS-­‐T-­‐REx	  
cells.	   24	   h	   after	   siRNA	   transfection,	   doxycyclin	   (1	   ng/mL	   or	   DMSO)	   was	   added	   with	   fresh	   medium	   for	  
additional	   48	   h,	   and	   total	   cell	   extracts	   were	   analyzed	   by	   Western	   blot.	   Ectopic	   RECQ5	   expression	   was	  
monitored	   by	   anti-­‐FLAG	   antibody.	   Blots	   were	   also	   probed	   with	   antibody	   raised	   against	   the	   full-­‐length	  






In	  order	  to	  induce	  chromatid	  breakage	  at	  CFSs,	  cells	  were	  treated	  with	  low	  dose	  of	  
aphidicolin	  for	  the	  last	  24	  h.	  As	  expected,	  aphidicolin	  treatment	  induced	  chromatid	  
breakage,	   and	   RECQ5	   depletion	   inhibited	   its	   formation	   in	   these	   cell	   lines.	   Ectopic	  
expression	  of	  wild-­‐type	  RECQ5	   in	   substitution	  of	   the	  endogenous	  RECQ5,	   restored	  
CFS	  expression.	  Importantly,	  when	  endogenous	  RECQ5	  was	  replaced	  with	  the	  S727A	  
mutant	   of	   RECQ5,	   chromatid	   breakage	   was	   impaired	   (Figure	   31),	   suggesting	   that	  
RECQ5	  phosphorylation	  on	  S727	  residue	  is	  important	  for	  CFS	  expression.	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  
Figure	   31.	   RECQ5	   phosphorylation	   on	   Ser727	   is	   required	   for	   expression	   of	   CFSs.	   Metaphase	   spread	  
analysis	   of	   U2OS	   TREx	   cell	   lines	   expressing	  WT	   or	   S727A	   versions	   of	   RECQ5	   upon	   doxycyclin	   treatment.	  
After	   24	   h	   of	   siRNA	   transfection	   for	   down-­‐regulation	   of	   endogenous	   RECQ5	   depletion,	   doxycyclin	   was	  
added	   to	   the	   medium	   for	   additional	   48	   h.	   24	   h	   before	   harvesting,	   cells	   were	   treated	   with	   0.2	   μM	  
aphidicolin,	   and	   during	   the	   last	   5	   h,	   nocodazole	   was	   added	   to	   trap	   cells	   in	   metaphase.	   At	   least	   100	  
metaphase	  spreads	  were	  analyzed	  for	  each	  condition	  in	  two	  independent	  experiments.	  The	  data	  represent	  
the	  mean	  +/-­‐	  S.D.	  
	  
	   Next,	   we	   analyzed	   the	   frequencies	   of	   DAPI-­‐positive	   anaphase	   bridges	   and	  
micronuclei	   formation	   in	   U2OS	   T-­‐REx	   cell	   lines	   expressing	   wild-­‐type	   or	   S727A	  
versions	   of	   RECQ5.	   Ectopic	   expression	   of	   wild-­‐type	   RECQ5	   on	   place	   of	   the	  




depleted	   cells.	   On	   the	   contrary,	  when	   S727A	  RECQ5	  was	   expressed	   in	   absence	   of	  
endogenous	  RECQ5,	  DAPI-­‐positive	  anaphase	  bridges	  and	  micronuclei	  were	  elevated	  
to	   levels	   observed	   in	   RECQ5-­‐depleted	   cells	   (Figure	   32,	   33),	   suggesting	   that	   RECQ5	  
phosphorylation	  at	  Ser727	  is	  necessary	  for	  proper	  sister	  chromatid	  separation.	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	   32.	   Suppression	   of	   bulky	   anaphase	   bridge	   formation	   depends	   on	   RECQ5	   phosphorylation	   at	  
Ser727.	  The	  frequency	  of	  bulky	  anaphase	  bridges	  in	  U2OS	  TREx	  cell	  lines	  expressing	  WT	  or	  S727A	  versions	  
of	   RECQ5	   was	   measured.	   After	   24	   h	   of	   siRECQ5	   transfection,	   doxycylin	   (or	   DMSO)	   was	   added	   to	   the	  
medium	   for	   additional	   48	   h,	   before	   cell	   fixation	   with	   formaldehyde	   and	   DAPI	   staining.	   At	   least	   100	  
anaphase	  cells	  were	  scored	  in	  two	  independent	  experiments.	  The	  data	  represent	  the	  mean	  +/-­‐	  S.D.	  
	  
	   	  We	   conclude	   that	   RECQ5	   phosphorylation	   at	   Ser727	   is	   fundamental	   for	  





	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	   33.	   Phosphorylation	   of	   RECQ5	   at	   Ser727	   is	   required	   to	   suppress	   formation	   of	   micronuclei.	   The	  
formation	  of	  micronuclei	  in	  U2OS	  TREx	  cell	  lines	  expressing	  WT	  or	  S727A	  versions	  of	  RECQ5	  was	  analyzed.	  
The	  condition	  used	  were	  the	  same	  as	  in	  Figure	  32,	  except	  that	  cyctochalasin	  B	  was	  added	  to	  the	  cell	  culture	  
for	   the	   last	   16	   h	   to	   block	   cytokinesis.	   At	   least	   300	   binucleated	   cells	   were	   analyzed	   in	   two	   independent	  
experiments.	  The	  data	  represent	  the	  mean	  +/-­‐	  S.D.	  
	  
5.5	  –	  Molecular	  mechanism	  underlying	  the	  action	  of	  RECQ5	  on	  CFSs	  during	  early	  
mitosis	  	  
	  
One	  of	  the	  characteristic	  features	  of	  RECQ5	  helicase	  is	   its	  ability	  to	  disrupt	  RAD51-­‐
ssDNA	   filaments.	   Stalled	   forks	   and,	   in	   general,	   replication	   intermediates	   contain	  
stretches	   of	   ssDNA	   that,	   theoretically,	   can	   be	   a	   suitable	   substrate	   for	   RAD51	  
filament	  formation.	  Interestingly,	  recent	  studies	  have	  revealed	  that	  RAD51	  filaments	  
assemble	  on	  stalled	  replication	  forks	  to	  protect	  nascent	  DNA	  strands	  from	  MRE11-­‐
dependent	   degradation	   [163].	   This	   could	   also	   be	   the	   case	   for	   CFSs,	  where	   stalled	  
replication	  forks	  tend	  to	  accumulate,	  especially	  in	  the	  presence	  of	  replication	  stress.	  
We	   therefore	   reasoned	   that	   RECQ5	   could	   disrupt	   RAD51	   filaments	   on	   persistent	  
replication	   intermediates	  at	  CFSs,	  allowing	  MUS81-­‐EME1	  cleavage.	  To	  address	   this	  




occupancy	  on	  CFSs	  in	  the	  absence	  and	  the	  presence	  of	  replication	  stress	  generated	  
by	  0.2	  μM	  aphidicolin.	  By	  ChIP	  assay,	  we	   found	   that	  aphidicolin	   treatment	  caused	  
increased	   binding	   of	   RAD51	   to	   CFSs,	   but	   not	   to	   the	   GAPDH	   gene.	   Importantly,	  
depletion	  of	  RECQ5	  caused	  a	  significant	  enrichment	  of	  RAD51	  at	  CFSs	  both	  in	  non-­‐
treated	   and	   aphidicolin-­‐treated	   cells	   as	   compared	   to	   mock-­‐depleted	   cells	   (Figure	  
34).	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	  34.	  RECQ5	  depletion	  promotes	  RAD51	  accumulation	  on	  CFSs.	  Cross-­‐linked	  chromatin	  of	  mock-­‐	  or	  
RECQ5	   depleted	   cells	   treated	   cultured	   in	   the	   presence	   of	   0.2	   μM	   aphidicolin	   (or	   DMSO)	   for	   24	   h	   was	  
immunoprecipitated	  with	  anti-­‐RAD51	  antibody.	  Immunoprecipitated	  DNA	  samples	  were	  analyzed	  by	  qPCR	  
using	  primer	  pairs	  for	  three	  different	  CFSs	  (FRA3B,	  FRA16D,	  FRA7H)	  and	  GAPDH	  as	  control.	  Data	  represent	  
the	  mean	  of	  three	  independent	  experiments.	  Error	  bars	  show	  S.D.	  
	  
	   RECQ5	   disrupts	   RAD51	   filaments	   in	   a	   reaction	   dependent	   on	   its	   helicase	  
activity	   and	   binding	   to	   RAD51	   [90].	   We	   therefore	   investigated	   the	   role	   of	   these	  
activities	   of	  RECQ5	   in	   its	   regulatory	   effect	   on	  RAD51	  binding	   to	  CFSs.	   For	   this,	  we	  
had	   already	   available	   U2OS	   T-­‐REx	   cell	   lines	   inducibly	   expressing	   RECQ5	   mutants	  
defective	   in	  helicase	  activity	   (K58R	   substitution	   in	  Walker	  A	  motif)	   and	   interaction	  
with	  RAD51	   (F666A	  substitution	   in	  RAD51-­‐binding	  domain),	   respectively	   [152].	  We	  
found	  that	  replacement	  of	  endogenous	  RECQ5	  with	  either	  of	  these	  mutants,	  but	  not	  
with	  wild-­‐type	   RECQ5,	   significantly	   increased	   RAD51	   occupancy	   at	   CFSs,	   providing	  




on	   late	   replication	   intermediates	   at	   CFSs	   (Figure	   35	   and	   Figure	   36a).	   Increased	  
RAD51	  binding	  to	  CFSs	  was	  also	  observed	  in	  cells	  expressing	  RECQ5	  S727A	  mutant,	  
suggesting	   that	   RECQ5	   processes	   these	   RAD51	   filaments	   during	   early	  mitosis	   in	   a	  
manner	  dependent	  on	  its	  phosphorylation	  by	  CDK1	  (Figure	  36b).	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	   	  
	  
Figure	  35.	  Western	  blot	  analysis	  of	  expression	  of	  WT,	  K58R	  and	  F666A	  variants	  of	  RECQ5-­‐Flag	  protein	  in	  
U2OS	   T-­‐REx	   cells.	   24	   h	   after	   siRNA	   transfection,	   doxycyclin	   (1	   ng/mL	   or	   DMSO)	   was	   added	   with	   fresh	  
medium	   for	   additional	   48	   h,	   and	   total	   cell	   extracts	   were	   analyzed	   by	   Western	   blot.	   Ectopic	   RECQ5	  
expression	  was	  monitored	  by	  anti-­‐FLAG	  antibody,	  while	  endogenous	  RECQ5	  down-­‐regulation	  was	  monitor	  
by	  anti-­‐RECQ5	  antibody.	  MCM7	  was	  used	  as	  loading	  control.	  
	  
To	   gain	   further	   support	   for	   the	  above	  hypothesis,	  we	  asked	  whether	  helicase	   and	  
RAD51-­‐binding	  activities	  of	  RECQ5	  are	  needed	  for	  expression	  of	  CFSs.	  We	  found	  that	  
if	  the	  K58R	  or	  F666A	  mutants	  of	  RECQ5	  were	  expressed	  in	  U2OS	  T-­‐REx	  cells	  on	  place	  
of	   endogenous	   RECQ5,	   aphidicolin-­‐induced	   chromatid	   breakage	   was	   inhibited	  
(Figure	  37),	  suggesting	  a	  functional	  role	  for	  RECQ5	  helicase	  activity	  and	  its	  binding	  to	  






	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure	   36.	  RAD51	   occupancy	   at	   CFSs	   in	   U2OS	   T-­‐Rex	   cell	   expressing	   RECQ5	  mutants.	  After	   endogenous	  
RECQ5	   down-­‐regulation	   and	   doxycyclin	   treatment	   for	   RECQ5	  mutant	   expression,	   cells	  were	   cross-­‐linked,	  
lysed	   and	   sonicated	   for	   ChIP.	   Fragmented	   chromatin	   was	   immunoprecipitated	   by	   a	   specific	   antibody	  
against	  RAD51,	  and	  the	  isolated	  DNA	  was	  used	  for	  qPCR	  analysis	  using	  specific	  primers	  for	  FRA3B,	  FRA16D,	  
FRA7H	   and	  GAPDH	   (negative	   control).	   The	   data	   represent	   the	  mean	   of	   three	   independent	   experiments.	  
Error	  bars	  show	  S.D.	  
	  





	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	   37.	   RECQ5	   helicase	   activity	   and	   its	   RAD51-­‐binding	   domain	   are	   necessary	   for	   CFS	   expression.	  
Metaphase	   spread	  analyses	  of	  U2OS	  T-­‐REx	  cells	  expressing	  WT,	  K58R	  and	  F666A	  versions	  of	  RECQ5-­‐Flag,	  
respectively.	  Cell	  culture	  conditions	  were	  the	  same	  as	   in	  Figure	  31.	  At	   least	  100	  metaphase	  spreads	  were	  
analyzed	  for	  each	  condition	  in	  two	  independent	  experiments.	  The	  data	  represent	  the	  mean	  +/-­‐	  S.D.	  
	  
	   Finally,	  we	  investigated	  whether	  the	  helicase	  activity	  of	  RECQ5	  and	  its	  ability	  
to	   interact	  with	  RAD51	  are	  needed	   for	   proper	   chromosome	   separation	   in	  mitosis.	  
For	   this,	  we	  measured	   the	   frequency	   of	  DAPI-­‐stained	   bulky	   anaphase	   bridges	   and	  
micronuclei	   in	   U2OS	   T-­‐REx	   cell	   lines	   expressing	   the	   K58R	   and	   F666A	   mutants	   of	  
RECQ5,	   respectively.	  We	   found	   that	   if	   either	   of	   these	  mutants	   was	   expressed	   on	  
place	   of	   endogenous	   RECQ5,	   the	   frequency	   of	   these	   aberrant	  mitotic	   phenotypes	  
was	  significantly	  increased	  as	  compared	  to	  cells	  expressing	  wild-­‐type	  RECQ5	  	  (Figure	  
38,	  39).	  
	   In	  conclusion,	  our	  data	  provide	  evidence	  that	  RECQ5	  acts	  during	  early	  mitosis	  
to	   eliminate	   RAD51	   filaments	   from	   stalled	   replication	   forks	   at	   CFSs	   and	   hence	  





	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	  38.	  Elevated	   frequency	  of	  bulky	  anaphase	  bridges	   in	  U2OS	  T-­‐REx	  cells	  expressing	  K58R	  or	  F666A	  
mutants	   of	   RECQ5.	   Cell	   culturing	   and	   analysis	   of	   DAPI-­‐stained	   anaphase	   bridges	   were	   performed	   as	   in	  
Figure	  32.	  At	  least	  100	  anaphase	  cells	  were	  analyzed	  in	  two	  independent	  experiments.	  The	  data	  represent	  
the	  mean	  +/-­‐	  S.D.	  
	  
	   	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	  39.	  RECQ5	  helicase	  activity	  and	   its	  binding	  to	  RAD51	  are	  required	  for	  suppression	  of	  micronuclei	  
formation.	  Cell	   culturing	   conditions	  were	   the	   same	   as	   in	   Figure	   33.	   At	   least	   400	   binucleated	   cells	   were	  
analyzed	  in	  two	  independent	  experiments.	  Error	  bars	  show	  S.D.	  
	  






Figure	  40.	  Model	  for	  the	  role	  of	  RECQ5	  in	  MUS81-­‐mediated	  resolution	  of	  stalled	  replication	  forks	  in	  early	  














6.	  Additional	  results	  
	  
6.1	  –	  Mechanism	  of	  the	  formation	  of	  DNA	  DSBs	  after	  CHK1	  inhibition	  
	  
When	   replication	   forks	   stall,	   DNA	   damage	   checkpoint	   kinases	   activate	   a	   signaling	  
cascade,	   spreading	   the	   signal	   to	   numerous	   effector	   proteins	   that	   regulate	   cell	  
physiology.	  Replication	  stress	  generates	  extended	  ssDNA	  tracks	  at	  replication	  forks,	  
and	   these	   serve	   as	   a	   signal	   to	   trigger	   replication	   checkpoint	   activation	   [164,	   165].	  
ATR	  kinase	  is	  the	  major	  player	  of	  the	  replication	  stress	  response,	  and	  it	  is	  involved	  in	  
fork	   stabilization,	   repair	   and	   restart.	   At	   the	   same	   time,	   ATR	   phosphorylates	   and	  
activates	  CHK1,	  which	  promotes	  cell	  cycle	  arrest	  and	  inhibits	  additional	  origin	  firing	  
[166].	   Previous	   studies	   have	   shown	   that	   CHK1	   inhibition	   promotes	   MUS81-­‐
dependent	   DSB	   formation	   [167].	   CHK1	   inhibition	   also	   promotes	   premature	   entry	  
into	   mitosis,	   excessive	   origin	   firing	   and	  massive	   ssDNA	   generation	   [168].	   For	   this	  
reason,	   we	   were	   interested	   to	   study	   whether	   RECQ5	   could	   have	   a	   role	   in	   DSB	  
formation	   upon	   CHK1	   inhibition	   along	   with	   the	   MUS81	   endonuclease.	   To	   inhibit	  
CHK1	  activity	   in	  vivo,	  we	  used	  the	  small	  molecule	  UCN-­‐01.	  When	  we	  treated	  HeLa	  
cells	  with	  UCN-­‐01	  for	  7	  h,	  we	  could	  not	  observe	  DSB	  formation	  by	  pulsed-­‐field	  gel	  
electrophoresis	   (PFGE;	   Figure	   1S	   lane	   3).	  We	   therefore	   synchronized	  HeLa	   cells	   at	  
G1/S	  transition	  by	  HU	  treatment	  for	  16	  h,	  and	  at	  1	  h	  after	  HU	  release,	  UCN-­‐01	  was	  
added	   for	   additional	   7	   h.	   Under	   these	   conditions,	   we	   could	   observe	   DSB	  





	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  
Figure	  S1.	  UCN-­‐01	  induces	  DSB	  formation	  only	  in	  S-­‐phase	  synchronized	  cells.	  HeLa	  cells	  were	  treated	  with	  
300	  nM	  UCN-­‐01	  for	  7	  h	  prior	  to	  and	  after	  synchronization	  in	  S-­‐phase	  by	  2	  mM	  HU	  (16	  h)	  as	  indicated.	  HU	  
synchronized	  cells	  were	   released	   for	  1	  h	   in	   fresh	  medium	  to	  allow	   replication	   restart.	  Genomic	  DNA	  was	  
isolated	  and	  analyzed	  by	  pulsed	  field	  electrophoresis.	  16	  h	  HU	  treatment	  did	  not	  induce	  DSB	  formation.	  The	  
bands	   in	   the	   wells	   correspond	   to	   intact	   genomic	   DNA.	   The	   lower	   band	   and	   the	   smear	   correspond	   to	  
fragmented	  DNA.	  	  	  
	  
	   Next,	   we	   used	   U2OS	   cell	   line	   to	   monitor	   DSB	   formation	   after	   UCN-­‐01	  
treatment.	  We	  treated	  asynchronous	  or	  HU-­‐synchronized	  U2OS	  cells	  by	  UCN-­‐01	  for	  
7	  h.	   Interestingly,	  we	  observed	  that	  HU	  synchronization	  was	  not	  required	  for	  UCN-­‐
01	  to	  induced	  DSB	  formation	  in	  U2OS,	  although	  it	  increased	  the	  amount	  of	  DSBs	  as	  
compared	   to	   asynchronous	   cells	   (Figure	   S2).	   We	   speculate	   that	   the	   differences	  
observed	  between	  HeLa	  and	  U2OS	  cells	  could	  arise	  from	  the	  fraction	  of	  the	  S	  phase	  
population;	  U2OS	  cell	  population	  has	  a	  higher	  percentage	  of	  S-­‐phase	  cells	  than	  HeLa	  





	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	  S2.	  UCN-­‐01	  promotes	  DSB	   formation	  without	  HU	  synchronization	   in	  U2OS	  cells.	  U2OS	  cells	  were	  
treated	  with	  300	  nM	  UCN-­‐01	   for	  7	  h	  prior	   to	  and	  after	  synchronization	  by	  HU	  treatment	   (see	  Figure	  S1).	  
DSB	  formation	  was	  monitored	  by	  pulsed	  field	  electrophoresis.	  	  
	  
	   Since	  DSB	  formation	  upon	  CHK1	  inhibition	  required	  the	  cells	  to	  be	  in	  S	  phase,	  
we	  wanted	  to	  determine	  whether	  these	  breaks	  were	  dependent	  on	  replication	  fork	  
movement.	   To	   this	   end,	  we	   treated	  U2OS	  with	  UCN-­‐01	   in	   the	   presence	   of	   a	   high	  
dose	   of	   aphidicolin,	   known	   to	   completely	   inhibit	   replicative	   DNA	   polymerases.	   By	  
PFGE,	  we	  observed	  that	  aphidicolin	  completely	  inhibited	  DSB	  formation	  upon	  CHK1	  





	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	   3S.	   DSB	   formation	   induced	   by	   CHK1	   inhibition	   depends	   on	   DNA	   replication.	   U2OS	   cells	   were	  
treated	  with	  300	  nM	  UCN-­‐01	  for	  10	  h	   in	  the	  absence	  or	  the	  presence	  of	  5μM	  aphidicolin.	   	  Genomic	  DNA	  
was	  isolated	  and	  analyzed	  by	  pulsed	  field	  electrophoresis.	  
	  
	   Our	   previous	   results	   showed	   that	   RECQ5	   and	   MUS81	   bind	   to	   CFSs	   where	  
replication	   intermediates	   accumulate,	   and	   where	   RECQ5	   facilitates	   MUS81-­‐
mediated	  cleavage	  of	  stalled	  replication	  forks	  in	  early	  mitosis.	  Therefore,	  we	  wanted	  
to	   investigate	  whether	  DSBs	   formed	  upon	  UCN-­‐01	   treatment	  depended	  on	  RECQ5	  
and	  MUS81.	  We	  down-­‐regulated	  RECQ5	  and	  MUS81	  in	  U2OS	  cells	  and	  then	  treated	  
them	  with	  UCN-­‐01	  for	  10	  h.	  We	  found	  that	  both	  MUS81	  and	  RECQ5	  were	  required	  
for	  DNA	  breakage	  induced	  by	  CHK1	  inhibition	  (Figure	  4S).	  Double-­‐depletion	  of	  these	  
proteins	  did	  not	   further	  decreased	  DSB	   levels,	   confirming	   that	  RECQ5	  and	  MUS81	  
work	   in	   the	   same	  pathway	   for	  DSB	   formation.	   The	   same	   results	  were	  obtained	   in	  





	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	  4S.	  UCN-­‐01-­‐induced	  DSBs	  depend	  on	  both	  RECQ5	  and	  MUS81.	  a)	  RECQ5	  or	  MUS81	  were	  depleted	  
in	  U2OS	  cells,	  and	  the	   last	  10	  h,	  UCN-­‐01	  (300	  nM)	  was	  added.	  DSB	  formation	  was	  monitored	  by	  PFGE.	  b)	  
Quantification	   of	   the	   gel	   shown	   in	   (a).	   The	   data	   represent	   the	  mean	  of	   three	   independent	   experiments.	  
Error	  bars	  show	  S.D.	  
	  
	   According	  to	  our	  results,	  RECQ5	  and	  MUS81	  are	  recruited	  on	  CFSs	  during	  an	  
early	  step	  of	  mitosis,	  and	  RO-­‐3306	  treatment	  prevented	  RECQ5	  and	  MUS81	  binding	  
to	   those	   regions.	   We	   therefore	   wanted	   to	   investigate	   whether	   UCN-­‐01-­‐induced	  
chromosome	  breakage	   is	   dependent	   upon	   entry	   of	   cells	   into	  mitosis.	   To	   this	   end,	  
UCN-­‐01	  was	   combined	  with	   nocodazole	   or	   RO-­‐3306	   treatment	   in	   U2OS	   cells,	   and	  
DSB	  formation	  under	  these	  conditions	  was	  analyzed	  by	  PFGE.	  Interestingly,	  blockage	  
of	   cells	   in	   prometaphase	   by	   nocodazole	   did	   not	   prevent	   DNA	   breakage.	   On	   the	  
contrary,	  blockage	  of	  cell	  at	  G2/M	  transition	  by	  RO-­‐3306	   treatment,	   inhibited	  DSB	  
formation	  (Figure	  5S),	  suggesting	  that	  in	  order	  to	  break,	  stalled	  replication	  forks	  and	  
other	  replication	  intermediates	  need	  to	  enter	  in	  mitosis	  where	  probably	  RECQ5	  and	  





	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	  5S.	  DSB	  formation	  induced	  by	  CHK1	  inhibition	  occurs	  upon	  entry	  into	  mitosis.	  a)	  U2OS	  cells	  were	  
treated	   for	   10	   h	   with	   300	   nM	   UCN-­‐01,	   9μM	   RO-­‐3306	   and	   200ng/mL]	   as	   indicated.	   Genomic	   DNA	   was	  
analyzed	   by	   PFGE.	  b)	   FACS	   analysis	   of	   U2OS	   cell	   treated	  with	   indicated	   drugs.	   Condition	   for	   treatments	  






DNA	   replication	   allows	   faithful	   duplication	   of	   the	   genetic	   material	   and	   its	  
segregation	   to	   daughter	   cells.	   However,	   replication	   forks	   encounter	   numerous	  
roadblocks	   during	   DNA	   synthesis,	   such	   as	   unrepaired	   DNA	   lesions,	   active	  
transcription	   complexes	   or	   secondary	   DNA	   structures,	   which	   can	   halt	   their	  
progression.	   Structure-­‐specific	   endonucleases	   play	   an	   important	   role	   in	   resolving	  
stalled	   replication	   forks	   and	   other	   aberrant	   structures	   arising	   in	   response	   to	  
replication	   perturbation.	   In	   recent	   years,	   a	   number	   of	   studies	   have	   shown	   that	  
chromosome	   segregation	   is	   heavily	   affected	   by	   unresolved	   replication	  
intermediates,	  generating	  the	  basis	  for	  genome	  instability	  and	  tumorigenesis	  [169].	  	  
	   	  The	   MUS81-­‐EME1	   endonuclease	   was	   shown	   to	   actively	   resolve	   toxic	  
replication	  intermediates	  at	  late	  replicating	  common	  fragile	  sites	  (CFSs)	  during	  early	  
mitosis	   [138,	   139].	   Under	   conditions	   of	   replication	   stress,	   CFSs	   are	   usually	   under-­‐
replicated	  and	  escape	  the	  G2/M	  checkpoint	  and,	  if	  not	  expressed,	  they	  can	  give	  rise	  
to	  anaphase	  DNA	  bridges	  and	  micronuclei,	  leading	  to	  loss	  of	  heterozygosity	  (LOH)	  or	  
aneuploidy.	  Earlier	  studies	  conducted	  by	  our	  collaborator	  Prof.	  Lumir	  Krejci,	  and	  also	  
by	  our	  laboratory,	  have	  shown	  that	  the	  MUS81-­‐EME1	  complex	  interacts	  with	  RECQ5	  
DNA	  helicase	  both	  in	  vitro	  and	  in	  vivo.	  Moreover,	  biochemical	  experiments	  revealed	  
that	   RECQ5	   could	   stimulate	   MUS81-­‐EME1-­‐mediated	   cleavage	   of	   3’-­‐flap	   DNA	  
structures	  [153].	  Therefore,	  our	  work	  focused	  on	  the	  biological	   function	  of	  RECQ5-­‐
MUS81	   interaction	   in	   response	   to	   replication	   stress.	   We	   have	   shown	   that	   the	  
absence	  of	  RECQ5	  in	  the	  cell	   impairs	  CFS	  expression	  that,	   in	  turn,	  causes	  anaphase	  
bridging,	  micronucleus	  formation	  and	  53BP1	  accumulation	  in	  the	  following	  G1	  phase	  
of	   the	   cell	   cycle.	  Moreover,	  we	   have	   found	   that	   RECQ5	  depletion	   leads	   to	   RAD51	  
accumulation	  on	  CFSs.	  Expression	  of	  RECQ5	  mutants	  with	  impaired	  helicase	  activity	  




CFSs,	   inhibited	  CFS	  expression	  and	  promoted	  aberrant	   sister	   chromatid	   separation	  
leading	  to	  genomic	  instability.	  Based	  on	  these	  findings,	  we	  propose	  that	  RECQ5	  has	  
a	   dual	   role	   in	   CFS	   expression:	   (i)	   it	   removes	   RAD51	   from	   aberrant	   replication	  
intermediates,	   a	   prerequisite	   for	  MUS81-­‐EME1	   cleavage;	   and	   (ii)	   it	   stimulates	   the	  
nuclease	  activity	  of	  MUS81-­‐EME1.	  This	  model	   is	   reminiscent	  of	   the	  model	  recently	  
proposed	   for	   the	   yeast	   Srs2	  DNA	  helicases	   that,	   like	  RECQ5,	  possess	   the	  ability	   to	  
dismantle	   Rad51	   nucleoprotein	   filaments	   [170,	   171].	   It	   has	   been	   shown	   that	   Srs2	  
interacts	  with	   the	  Mus81-­‐Mms4	   endonuclease,	   promoting	   its	   nuclease	   activity	   on	  
different	  DNA	  substrates	  and	  stripping	  RAD51	  filament	  from	  ssDNA,	  thus	  generating	  
a	  suitable	  substrate	  for	  Mus81-­‐Mms4	  [170].	  	  
	   Consistent	  with	   our	   findings,	   it	   has	   been	   shown	   that	   the	   fission	   yeast	   RecQ	  
homolog,	   Rqh1,	   promotes	   correct	   chromosome	   segregation	   at	   rDNA	   array,	   and	  
Rqh1	  mutant	   cells	   show	   delayed	   anaphase	   progression	   and	   lagging	   chromosomes	  
[172].	   Moreover,	   another	   publication	   demonstrated	   that	   the	   absence	   of	   Rqh1	  
impairs	  Mus81-­‐Eme1-­‐mediated	  cleavage	  of	   stalled	   forks	  after	  HU	   treatment	   [110].	  
Interestingly,	  it	  has	  been	  also	  shown	  that	  loss	  of	  RECQ5	  in	  Drosophila	  melanogaster	  
embryos	  leads	  to	  an	  increase	  in	  the	  frequency	  of	  anaphase	  bridge	  formation	  [173].	  
Thus,	   it	   appears	   that	   the	   cooperation	  between	  a	  RecQ-­‐type	  DNA	  helicase	  and	   the	  
Mus81	  endonuclease	  in	  the	  resolution	  of	  replication	  intermediates	  during	  mitosis	  is	  
evolutionary	  conserved.	  
	   We	  have	   shown	   that	   RECQ5	  depletion	   leads	   to	   the	   formation	   of	   bulky	  DNA	  
bridges	  and	  PICH-­‐positive	  UFBs,	  where	   the	   latter	  are	   considered	   to	  originate	   from	  
CFSs	   if	   they	   also	   contain	   FANCD2	   foci.	   Therefore,	   it	   would	   be	   interesting	   to	  
distinguish	  those	  UFBs	  arising	  from	  centromeric	  regions	  and	  those	  from	  CFSs.	  	  
	   A	  previous	   study	  demonstrated	   that	   depletion	  of	   TopBP1/Dpb11	   in	  budding	  
yeast	   and	   chicken	   cells,	   increases	   DAPI-­‐positive	   bridges	   and	   BLM-­‐positive	   UFBs	  




53BP1	  nuclear	  body	  accumulation	  and	  inhibits	  SLX4	  foci	  formation	  in	  mitosis	  [175].	  
Since	  SLX4	  acts	  as	  a	   scaffold	   for	  SLX1,	  XPF-­‐ERCC1	  and	  MUS81-­‐EME1,	  and	  all	   these	  
endonucleases	   have	   been	   demonstrated	   to	   prevent	   chromosome	   segregation	  
defects,	  it	  is	  plausible	  to	  propose	  that	  RECQ5	  also	  associates	  with	  the	  TopBP1/SLX4	  
scaffold.	  One	   can	   speculate	   that	  depletion	  of	   TopBP1	   can	  disrupt	   the	  entire	   SLX4-­‐
MUS81-­‐RECQ5	   complex,	   therefore	   placing	   RECQ5	   in	   the	   pathway	   for	   resolution	  
interlinked	   chromosomes	   in	  mitosis.	   It	   is	   possible	   that	   RECQ5	   can	   stimulate	   other	  
endonucleases	  present	  in	  this	  complex.	  	  
	   Work	   in	   Prof.	   Lumir	   Krejci's	   laboratory	   has	   revealed	   that	   RAD51	   inhibits	  
MUS81-­‐EME1-­‐mediated	  cleavage	  of	  3’-­‐flaps	  in	  vitro	  [153],	  and	  we	  have	  shown	  that	  
the	  helicase	  and	  RAD51-­‐binding	  activities	  of	  RECQ5	  are	  required	  to	  promote	  correct	  
chromosome	   segregation	   and	   to	   prevent	   RAD51	   binding	   to	   CFSs.	   Interestingly,	  
studies	   conducted	   in	  budding	   yeast	   and	  mammalian	   cells	   have	   shown	   that	  RAD51	  
over-­‐expression	  induces	  anaphase	  bridge	  formation	  [174]	  and	  promotes	  aneuploidy	  
and	  chromosomal	  rearrangements	  [176].	  Thus,	  it	  would	  be	  interesting	  to	  study	  the	  
effect	  of	  RAD51	  over-­‐expression	  on	  aphidicolin-­‐induced	  breakage	  of	  CFSs,	  and	  also	  
to	  study	  micronucleus	  and	  anaphase	  bridge	  formation	  in	  this	  setting.	  Since	  our	  study	  
showed	  that	  RECQ5	  evicts	  RAD51	  from	  replication	  intermediates	  on	  CFSs,	  we	  could	  
expect	   that	   RAD51	   over-­‐expression	   would	   counteract	   MUS81-­‐EME1	   cleavage	  
activity	  on	  replication	  intermediates	  at	  CFS,	   leading	  to	   impairment	  of	  chromosome	  
segregation.	   It	   would	   be	   also	   interesting	   to	   test	   whether	   the	   observed	   defect	   in	  
chromosome	  segregation	  of	  RECQ5-­‐depleted	  cells	  is	  dependent	  on	  the	  presence	  of	  
RAD51.	  	  	  	  	  	  
	   We	   have	   found	   that	   RECQ5	   is	   phosphorylated	   by	   CDK1	   on	   Ser727	   in	   early	  
mitosis,	   and	   this	   phosphorylation	   is	   required	   for	   CFS	   expression	   and	   proper	  
chromosome	   segregation.	   Mus81-­‐Mms4	   has	   been	   shown	   to	   be	   hyper-­‐




for	   chromosome	   segregation	   in	   yeast	   [177].	   Although	   the	   function	   of	   RECQ5	  
phosphorylation	   is	   elusive,	   we	   provided	   evidence	   that	   it	   is	   involved	   in	   RAD51	  
displacement	   from	  CFSs,	   since	   expression	   of	   RECQ5	   S727A	  mutant	   lead	   to	   RAD51	  
accumulation	  on	  these	  regions.	  Interestingly,	  Ser727	  is	  located	  in	  close	  proximity	  to	  
the	   RAD51	   binding	   domain,	   therefore	   its	   phosphorylation	   could	   positively	   affect	  
RECQ5-­‐RAD51	   interaction	  that	   is	   required	   for	   the	  recruitment	  of	  RECQ5	  on	  RAD51	  
filaments	  and	  their	  disruption	  by	  RECQ5.	  
	   Based	   on	   our	   findings,	  we	   propose	   a	  model	  wherein	   RECQ5	   counteracts	   an	  
inhibitory	   effect	   of	   RAD51	   on	   MUS81-­‐EME1-­‐mediated	   cleavage	   of	   replication	  
intermediates	   in	   mitosis	   (Figure	   40).	   Studies	   have	   shown	   that	   RAD51	   filaments	  
assemble	   on	   stalled	   replication	   forks	   to	   prevent	   degradation	   of	   the	   nascent	   DNA	  
strands	   by	   the	   MRE11	   complex	   [163].	   These	   structures	   could	   escape	   the	   G2/M	  
checkpoint	   and	   enter	   into	   mitosis	   where	   they	   would	   hamper	   sister	   chromatid	  
segregation	  by	   inhibiting	  MUS81-­‐EME1	  cleavage.	  We	  propose	  that	   in	  early	  mitosis,	  
MUS81	   endonuclease	   is	   recruited	   to	   stalled	   replication	   forks	   by	   SLX4	   and	   in	   turn	  
recruits	  RECQ5	  as	  we	  found	  that	  the	  association	  of	  RECQ5	  with	  CFSs	  is	  dependent	  on	  
MUS81.	  Upon	  recruitment,	  RECQ5	  removes	  RAD51	  filament	  formed	  on	  the	  leading	  
strand	  arm	  of	  the	  fork	  and	  stimulates	   fork	  cleavage	  by	  the	  MUS81-­‐EME1	  complex.	  
RECQ5	   recruitment	   and/or	   its	   RAD51	   filament	   disruption	   activity	   are	   driven	   by	  
CDK1-­‐dependent	  phosphorylation	  of	  RECQ5	  at	  Ser727.	  If	  RECQ5	  is	  absent	  in	  the	  cell,	  
MUS81-­‐EME1	   cannot	   cleave	   replication	   intermediates	   because	   of	   the	   presence	   of	  
RAD51.	   RAD51	   persistency	   on	   replication	   intermediates	   does	   not	   impede	  
chromosome	   segregation,	   however,	   the	   cell	   will	   inevitably	   go	   through	   to	   an	  
aberrant	   anaphase	   separation,	   leading	   to	   genomic	   instability.
	  79	  
	  
_______________________________________________MATERIAL	  AND	  METHODS	  
80	  
	  
9.	  Material	  and	  Methods	  
	  
Cell	  culture	  
U2OS	   and	   HeLa	   cells	   were	   maintained	   in	   Dulbecco	   Modified	   Eagle's	   Medium	  
(DMEM;	   Invitrogen)	   supplemented	   with	   10%	   fetal	   calf	   serum	   (FCS;	   Life	  
Technologies)	   and	   streptomycin/penicillin	   (100	   U/mL)	   at	   37°C	   in	   a	   humidified	  
incubator	   containing	   5%	   CO2.	   U2OS	   T-­‐REx	   cell	   lines	   expressing	   pAll-­‐In-­‐One	   (pAIO)	  
vector	   (WT,	   K58R,	   F666A	   and	   S727A	   RECQ5	   variants),	   were	   cultivated	   in	   DMEM	  
supplemented	   with	   10%	   FBS	   (Tet-­‐free	   approved),	   streptomycin/penicillin	   (100	  
U/mL),	  1	  µg/mL	  puromycin	  and	  50µg/mL	  hygromycin	  B.	  
	  
Small-­‐interfering	  RNA	  (siRNA)	  transfection	  
U2OS,	  HeLa	  or	  U2OS	  T-­‐REx	  cells	  were	  seeded	  in	  DMEM	  complete	  medium	  (for	  U2OS	  
T-­‐Rex	   cells	   the	   medium	   was	   supplemented	   with	   puromycin	   and	   hygromycin)	   to	  
reach	  a	  cell	  confluency	  of	  30-­‐40%	  at	   the	  day	  of	   transfection.	  For	   transfection	  on	  a	  
10-­‐cm	  plate,	  15	  μL	  of	  Lipofectamine	  RNAiMAX	  (Invitrogen)	  was	  mixed	   in	  250	  μL	  of	  
OptiMEM	  medium	  (antibiotic	  free)	   in	  a	  1.5-­‐mL	  Eppendorf	  tube.	  In	  a	  separated	  1.5-­‐
mL	   Eppendorf	   tube,	   the	   siRNA	   was	   mixed	   with	   250	   μL	   of	   OptiMEM	   medium	   to	  
obtain	   a	   final	   siRNA	   concentration	  of	   40	   nM.	  After	   briefly	   vortexing	   and	   spinning-­‐
down,	   the	   siRNA	   mix	   was	   added	   to	   the	   RNAiMAX-­‐OptiMEM	   tube.	   After	   15-­‐min	  
incubation,	  the	  siRNA	  complexes	  were	  added	  dropwise	  to	  the	  plate	  containing	  5	  mL	  
of	   complete	   medium	   to	   get	   a	   final	   volume	   of	   5.5	   mL,	   and	   gently	   swirled	   before	  
returning	  plates	  to	  the	  incubator.	  After	  24	  h	  the	  medium	  was	  exchanged	  with	  fresh	  
DMEM	   medium.	   48	   or	   72	   h	   after	   transfection,	   cells	   were	   used	   for	   following	  
treatments	  or	  used	  for	  experiments.	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Lyophilized	   siRNA	   oligonucleotides	   purchased	   from	   Microsynth	   were	   dissolved	   in	  
distilled	  water.	  	  
For	  RECQ5	  expression	  in	  U2OS	  TREx	  cell	  lines,	  endogenous	  RECQ5	  was	  depleted	  for	  
a	   total	   time	  of	   72	  h.	  After	   24	  h	  of	   transfection,	   1	   ng/mL	  doxycyclin	  was	   added	   to	  
induce	  expression	  of	  WT,	  F666A,	  S727A,	  or	  K58R	  RECQ5	  variants	  for	  additional	  48	  h.	  
Sequences	  of	  siRNA	  oligonucleotides	  used	  in	  this	  study:	  
Gene	  target	   Abbreviation	  used	  	   Oligonucleotide	  sequence	  
Luciferase	   siCtrl	   CGUACGCGGAAUACUUCGAdTdT	  
	  
RECQ5	   siRECQ5#1	   GGAGAGUGCGACCAUGGCUdTdT	  
	  
RECQ5	   siRECQ5#2	   CAGGUUUGUCGCCCAUUGGAAdTdT	  
	  




Cells	   grown	  on	   cover	   slips,	   transfected	   or	   treated	  with	   drugs,	  were	   fixed	  with	   4%	  
formaldehyde.	   After	   several	   washes	   with	   PBS,	   cells	   were	   permeabilized	   in	   cold	  
methanol	  (-­‐20°C)	  or	  in	  50:50	  methanol/acetone	  mix	  (-­‐20°C)	  for	  15	  min	  at	  -­‐20°C.	  Cells	  
were	  then	  washed	  with	  PBS	  and	  blocked	  in	  5%	  BSA/PBS	  solution	  for	  45	  min.	  Cover	  
slips	  were	  then	  incubated	  with	  the	  appropriate	  primary	  antibody,	  diluted	  in	  5%	  BSA,	  
at	  4°C	  O.N.	  The	  following	  day,	  cover	  slips	  were	  washed	  several	  times	  with	  PBS	  and	  
incubated	  with	   the	   secondary	   antibody	   for	   45	  min	   at	   RT.	  After	  washing	  with	   PBS,	  
cover	  slips	  were	  mounted	  with	  Vectashield	  medium	  containing	  DAPI.	  The	  mounted	  
slides	  were	  left	  to	  dry	  at	  RT	  for	  30	  min	  and	  then	  sealed	  with	  nail	  polish.	  Slides	  were	  
analyzed	  with	  a	  Leica	  DM2700	  upright	  fluorescent	  microscope.	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For	  anaphase	  bridge	  analysis,	   cells	  were	  synchronized	  with	  9	  μM	  RO-­‐3306	   for	  16h	  
before	   releasing	   the	   cells	   first	   in	   1X	  PBS	   for	   5	  min	   at	   RT	   and	  eventually	   in	  DMEM	  
medium	   for	   a	   total	   time	   of	   1.5	   h	   at	   37°C.	   After	   RO-­‐3306	   release,	   cells	   were	  
simultaneously	   crosslinked	   and	   permeabilized	   in	   a	   PTEM	  buffer	   (20	  mM	  PIPES	   pH	  
6.8,	   10	  mM	   EGTA,	   0.2%	   Triton	   X-­‐100,	   1	  mM	  MgCl2)	   containing	   4%	   formaldehyde.	  
Washing	  steps	  were	  performed	  in	  PBS	  containing	  0.2	  %	  Triton-­‐X.	  	  
List	  of	  antibodies	  and	  dilutions	  used	  in	  this	  study:	  	  	  
Antibody	   Company	  	   Catalog	  number	   Dilution	  
53BP1	  rabbit	  polyclonal	   Santa	  Cruz	   sc-­‐22760	   1:200	  
Cyclin	  A	  mouse	  monoclonal	   Santa	  Cruz	   sc-­‐271682	   1:50	  
PICH	  mouse	  monoclonal	   Millipore	   04-­‐1540	   1:50	  
	  
Metaphase	  chromosome	  analysis	  
U2OS	  cells	  were	   seeded	   in	  10-­‐cm	  dishes	  and	   transfected	  with	   siRNA	  or	   treated	  as	  
indicated	  in	  Figure	  legends.	  5h	  before	  harvesting,	  200	  ng/mL	  nocodazole	  was	  added	  
to	  the	  medium.	  Cells	  were	  harvested	  by	  mitotic	  shake-­‐off	  and	  collected	  in	  a	  15-­‐mL	  
tube.	  After	  centrifugation	  for	  5	  min	  at	  4°C	  (2000	  x	  g),	  the	  supernatant	  was	  removed	  
and	   the	  pellet	   resuspended	   in	  1	  mL	  of	  DMEM.	  8	  mL	  of	  a	  75	  mM	  KCl	   solution	  was	  
added	   to	   the	   cells	   and	  afterwards	   they	  were	   incubated	  at	  37°C	   for	  15	  min.	   In	   the	  
meantime,	   Carnoy's	   buffer	   was	   prepared	   (75%	  methanol,	   25%	   glacial	   acetic	   acid)	  
and	  5	  mL	  added	  to	  the	  KCl	  solution	  for	  15	  min	  at	  RT.	  The	  fixing	  steps	  with	  Carnoy's	  
buffer	  were	  repeated	  3	  times	  with	  8	  mL	  of	  Carnoy’s	  buffer	  for	  each	  incubation.	  Cells	  
were	  then	  spread	  on	  slides	  drop-­‐wise	  and	  let	  dry	  O.N.	  at	  RT.	  The	  following	  day,	  dried	  
slides	   were	   mounted	   with	   mounting	   media	   and	   DAPI	   (Vectashield).	   Chromosome	  
spreads	   were	   analyzed	   on	   a	   Leica	   DM2700	   upright	   fluorescent	   microscope	   and	  
visible	  gaps/breaks	  were	  quantified	  for	  each	  spread.	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Micronuclei	  assay	  	  
Cells	  were	   grown	  on	   cover	   slips	   in	   6-­‐well	   plates.	   16	   h	   before	   fixation,	   cell	   culture	  
medium	  was	  supplemented	  with	  2	  µg/mL	  cytochalasin	  B	  to	  block	  cells	  in	  cytokinesis.	  
Cells	  were	   fixed	  with	   4%	   formaldehyde	   for	   10	  min	   and	  mounted	  with	  Vectashield	  
mounting	  media	  containing	  DAPI.	  For	  quantification,	  only	  DAPI-­‐stained	  binucleated	  
cells	  were	  counted,	  and	  distinct	  micronuclei	  were	  considered	  as	  positive.	  	  	  	  
	  
Western-­‐blot	  analysis	  
Cell	  were	  suspended	  in	  a	  50	  mM	  Tris-­‐HCl	  buffer	  (pH	  7.5)	  containing	  120	  mM	  NaCl,	  
20	  mM	  NaF,	  1	  mM	  EDTA,	  6	  mM	  EGTA,	  15	  mM	  Na-­‐Pyrophosphate	  and	  0.5%	  NP-­‐40,	  
and	   sonicated	   for	   5	  min	   with	   a	   Diagenode	   sonicator.	   Cellular	   debris	   was	   isolated	  
from	  soluble	  fraction	  by	  centrifugation	  at	  18000	  x	  g	  for	  30	  min	  at	  4°C.	  Samples	  were	  
subjected	   to	   SDS	   PAGE.	   Separated	  proteins	  were	   transferred	   to	   a	  Hybond-­‐P	   PVDF	  
membrane	  (GE	  Healthcare)	   in	  a	  semi-­‐dry	  apparatus	  (Sigma)	  for	  approx.	  100	  min	  at	  
0.8	  mA/cm2.	  The	  membrane	  was	  blocked	  with	  5%	  non-­‐fat	  dry	  milk	  in	  TBS-­‐T	  (20	  mM	  
Tris-­‐HCl	   pH	   7.4,	   150	   mM	   NaCl,	   0.1%	   (v/v)	   Tween-­‐20)	   for	   1	   h.	   Afterwards,	   the	  
membrane	  was	  incubated	  with	  the	  respective	  primary	  antibody	  in	  5%	  milk/TBS-­‐T	  at	  
4°C	  O.N.	  The	  membrane	  was	  then	  washed	  three	  times	  in	  TBS-­‐T	  and	  incubated	  with	  
anti-­‐mouse	  or	  anti-­‐rabbit	  horseradish	  peroxidase-­‐coupled	  (HRP)	  secondary	  antibody	  
(1:10000	   and	   1:5000	   dilution,	   respectively)	   for	   45	   min	   at	   RT.	   Afterwards,	   the	  
membrane	   was	   washed	   three	   times	   with	   TBS-­‐T	   and	   bands	   were	   detected	   by	  
luminol-­‐based	  reaction	  using	  a	  chemiluminescence	  reagent	  (Pierce).	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Antibody	  	   Company	  	   Catalog	  number	   Dilution	  
FLAG	  mouse	  monoclonal	   Sigma	   F1804	   1:500	  
MCM7	  mouse	  monoclonal	   Sigma	   M7931	   1:2000	  
MUS81	  mouse	  monoclonal	   Sigma	   M1445	   1:2000	  
RECQ5	  pSer727	  rabbit	  
polyclonal	  
Janscak	  Lab	   	   1:2000	  
H3	  pSer10	  rabbit	  polyclonal	   Millipore	   06-­‐570	   1:1000	  
RECQ5	  rabbit	  polyclonal	   Janscak	  Lab	   	   1:2000	  
TFIIH	  rabbit	  polyclonal	   Santa	  Cruz	   sc-­‐293	   1:2000	  
	  
Chromatin-­‐Immunoprecipitation	  (ChIP)	  assay	  
ChIP	  experiments	  were	  done	  with	   the	  ChIP-­‐IT®	  Express	  kit	   (Active	  Motif)	  as	  described	  
previously	  with	  minor	  modifications	  [144].	  Briefly,	  U2OS	  cells	  were	  seeded	  in	  a	  10-­‐cm	  
plate	  and	  transfections	  of	  indicated	  siRNAs	  were	  performed	  twice	  at	  24	  h	  and	  48	  h	  post	  
seeding.	  Where	  indicated,	  aphidicolin	  (0.4	  µM)	  and/or	  RO-­‐3306	  (9	  µM)	  were	  added	  to	  
cells	  after	  2	  days	  of	   first	  siRNA	  transfection.	  Cells	  were	  crosslinked	  24	  h	   later	  with	  1X	  
formaldehyde	  solution	  [1.1%	  formaldehyde,	  10	  mM	  NaCl,	  0.1	  mM	  EDTA	  (pH	  8.0),	  5	  mM	  
HEPES	   (pH	   7.9)]	   at	   room	   temperature	   for	   exactly	   15	   min,	   followed	   by	   addition	   of	  
glycine	   solution	   (125	   mM,	   let	   sit	   at	   room	   temperature	   for	   5	   min)	   to	   quench	   the	  
crosslinking	  reaction.	  Cells	  were	  harvested	  and	  collected	  by	  centrifugation	  at	  1200	  rpm	  
in	   a	   refrigerated	   centrifuge	   for	   10	   min.	   Cells	   were	   then	   washed	   twice	   with	   PBS	  
containing	   0.5%	   Igepal.	   Chromatin	   fragments	   used	   in	   immunoprecipitation	   reactions	  
were	  prepared	  by	  shearing	  of	  crosslinked	  chromatin	  using	  a	  bioruptor	  sonication	  device	  
(Diagenode).	  Ten	  percent	  of	  the	  sonicated	  chromatin	  were	  stored	  at	  -­‐80°C	  for	  use	  as	  an	  
input	   sample.	   For	   each	   ChIP	   reaction,	   sonicated	   chromatin	   (7.5	   µg)	   was	  
immunoprecipitated	  O.N.	  at	  4°C	  with	  either	   indicated	  antibody	  or	  a	  control	   IgG	  (4	  -­‐	  5	  
µg	   each).	   After	   washing,	   immunocomplexes	   were	   eluted	   from	   the	   beads	   and	   de-­‐
crosslinked	  according	  to	  the	  manufacturer’s	  instructions	  (Active	  Motif).	  ChIP	  and	  input	  
samples	  were	   purified	  with	   the	  QIAquick	   PCR	   Purification	   Kit	   (Qiagen)	   and	   DNA	  was	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eluted	   with	   50	   µl	   of	   sterile	   water.	   At	   least	   three	   independent	   experiments	   were	  
performed	   for	   each	   ChIP.	   In	   each	   case,	   eluted	   DNA	   sample	   (2	   –	   3	   µl)	   was	   used	   in	  
quantitative	  real-­‐time	  PCR	  (q-­‐PCR)	  analysis	  in	  triplicate	  on	  a	  Roche	  LightCycler	  480	  Real-­‐
time	  PCR	  system	  with	  the	  use	  of	  Roche	  LightCycler	  480	  DNA	  SYBR	  Green	   I	  master	   for	  
each	  primer	  pair.	  Data	  were	  analysed	  using	  the	  Pfaffl’s	  method	  as	  described	  previously	  
[144].	  Fold	  enrichment	  of	  each	  target	  region	  was	  calculated	  as	  ratio	  of	  the	  amount	  of	  
immunoprecipitated	  DNA	  estimated	  for	  the	  specific	  versus	  control	  IgG	  antibody.	  	  
	  
Antibodies	  used	  for	  ChIP	  in	  this	  study:	  
Antibody	   Company	   Catalog	  number	  
γ-­H2AX	   Ser139	   mouse	  
monoclonal	  
Millipore	   JBW301	  
53BP1	  rabbit	  polyclonal	   Novus	  Biological	   NB100-­‐304	  
MUS81	  mouse	  monoclonal	   Abcam	   ab14387	  
RAD51	  rabbit	  polyclonal	   Santa	  Cruz	   sc-­‐8349	  
RECQ5	  rabbit	  polyclonal	   Janscak	  Lab	   	  
	  
Primers	  used	  for	  qPCR	  in	  this	  study:	  
Primer	  Name	   Sequence	  5’-­‐3’	  
FRA3B	   CACTTCCTAACAGGCCCAAA	  
CCTCCACTTCTCCTCCCTCT	  
FRA16D	   TCCTGTGGAAGGGATATTTA	  
CCCCTCATATTCTGCTTCTA	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FRA7H	   TAATGCGTCCCCTTGTGACT	  
GGCAGATTTTAGTCCCTCAGC	  
GAPDH	   CCCTCTGGTGGTGGCCCCTT	  
GGCGCCCAGACACCCAATCC	  
	  
FACS	  analysis	  	  
For	  cell	  cycle	  analysis,	  cells	  were	  detached	  from	  the	  plate	  with	  trypsin.	  Afterwards,	  
the	   number	   of	   cells	   was	   counted	   to	   have	   a	   density	   of	   1.0*106	   per	   sample.	   After	  
washing	  with	  PBS,	  cells	  were	  fixed	  with	  1	  mL	  of	  70%	  cold	  ethanol	  added	  drop-­‐wise.	  
After	  30	  min	  of	  incubation	  in	  ethanol	  (the	  sample	  can	  be	  stored	  in	  ethanol	  at	  4°C	  up	  
to	  3	  weeks),	   cells	  were	  washed	  with	  PBS	  and	   resuspended	   in	  500	  µL	  of	  PBS.	  Cells	  
were	   then	   treated	   with	   100	   µg/mL	   RNase	   A	   at	   37°C	   for	   30	   min.	   Finally,	   cell	  
suspension	  was	   incubated	  with	   20	   µg/mL	   propidium	   iodide	   (PI)	   for	   30	  min	   in	   the	  
dark,	  followed	  by	  FACS	  analysis	  with	  a	  CyAn	  ADP	  Analyzer	  flow	  cytometer.	  	  	  
	  
Pulsed-­‐field	  gel	  electrophoresis	  (PFGE)	  
For	  plug	  preparation,	  1.5%	  LMT	  (low	  melting	  temperature)	  agarose	  (SeaPlaque	  GTG	  
agarose,	  Lonza)	  was	  dissolved	  in	  PBS	  in	  the	  microwave,	  and	  incubated	  in	  50°C	  water	  
bath	  until	   the	  use.	  Cells	  were	   trypsinized,	  collected	   in	  a	  Falcon	  tube	   (including	   the	  
PBS	   supernatant)	   and	  washed	  with	   cold	   PBS.	   Afterwards,	   cells	   were	   counted	   and	  
resuspended	  in	  PBS	  to	  have	  a	  1*106/100	  µL	  concentration.	  Cells	  were	  equilibrated	  at	  
50°C,	   followed	   by	   the	   addition	   of	   100	   μL	   agarose,	   and	   finally,	   the	   mixture	   was	  
transfered	   into	  PFGE	  plugs.	  Plugs	  were	   let	  dry	   for	  at	   least	  15	  min.	  The	  plugs	  were	  
then	  incubated	   in	   lysis	  buffer	  (100	  mM	  EDTA,	  pH	  8.0,	  0.02%	  sodium	  deoxycholate,	  
_______________________________________________MATERIAL	  AND	  METHODS	  
87	  
	  
1%	   sodium	   lauryl	   sarcosine)	   supplemented	   with	   20	   μg/mL	   proteinase	   K	   (Roche).	  
Plugs	  were	   incubated	   for	  36-­‐72	  h	  at	  37°C,	  and	   then	  washed	  3	   times	  with	  washing	  
buffer	  (20	  mM	  Tris-­‐HCl,	  50	  mM	  EDTA,	  pH	  8.0)	  for	  30	  min/wash.	  At	  this	  step,	  plugs	  
were	  stored	  at	  4°C	  or	   immediately	  used	  for	  electrophoresis	  analysis.	  For	  PFGE	  gel,	  
0.9%	   pulse	   field	   certified	   agarose	   (Pulse	   Field	   Certified	   Agarose,	   Bio-­‐Rad)	   were	  
dissolved	  in	  0.5X	  TBE	  in	  microwave,	  and	  incubated	  at	  50°C	  in	  water	  bath	  for	  at	  least	  
15	  min	  before	  casting.	  
Setting	  for	  the	  PFGE	  chamber	  (Bio-­‐Rad):	  
BLOCK	   I	   II	   III	  
TIME	  (h)	   9	   6	   6	  
INCLUDED	  
ANGLE	  
120	   117	   112	  
V/cm	   5.5	   4.5	   4.0	  
SWITCH	  (s)	   30-­‐18	   18-­‐9	   9-­‐5	  
	  
Gel	  electrophoresis	  was	   let	  run	  O.N.	  using	  the	  settings	   listed	   in	  the	  previous	  table.	  
The	   gel	   was	   stained	   with	   EtBr	   solution	   for	   30	   min	   and	   analyzed	   with	   an	   Alpha	  
Innotech	  AlphaImager	  Gel	   Documentation	   Station.	   The	   ImageJ	   Software	  was	   used	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